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ABSTRACT 
NEW INSIGHTS INTO THE ROLE OF ANTIMICROBIALS OF XENORHABDUS IN 
INTERSPECIES COMPETITION 
 
by 
Kristin J. Ciezki 
 
The University of Wisconsin – Milwaukee, 2017 
Under the Supervision of Professor Steven A. Forst 
 
Xenorhabdus spp. are symbionts of entomopathogenic nematodes and pathogens of susceptible 
insects. The nematodes penetrate the insect midgut to enter the hemocoel where Xenorhabdus 
bacteria are released, transitioning to their pathogenic stage. During nematode invasion microbes 
from the insect gut translocate into the hemocoel. In addition, different species of nematodes 
carrying specific strains of Xenorhabdus can invade a single insect. Xenorhabdus spp thereby 
engage in competition with both related strains and nonrelated gut microbes. In complex media 
Xenorhabdus spp produce diverse antimicrobial compounds whose functions in biological systems 
remain poorly understood. R-type bacteriocins are contractile phage-tail-like structures that are 
bactericidal towards related bacterial species. They are encoded by remnant P2-type prophage in 
which the C-terminal region of the tail fiber protein determines target-binding specificity. 
Xenorhabdus nematophila and Xenorhabdus bovienii produce R-type bacteriocins 
(xenorhabdicins) that are selectively active against different Xenorhabdus and Photorhabdus 
species. In this study we analyzed the P2-type remnant prophage clusters in the draft sequences of 
nine strains of Xenorhabdus bovienii. The C-terminal tail fiber region in each of the respective 
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strains was unique, consisting of mosaics of modular units. The intergenic regions between the 
main tail fiber gene (xbpH) and the sheath gene (xbpS) contained a variable number of genes 
encoding tail fiber fragment modules that were apparently exchanged between strains. 
Xenorhabdicins purified from three different X. bovienii strains isolated from the same nematode 
species displayed distinct activities against each other. Competition experiments revealed that 
xenorhabdicin activity was predictive of competitive outcomes between two of the strains while 
other determinants besides xenorhabdicins were primarily involved in the competitive success 
between the other strains, indicting that several factors may be involved in determining the 
outcome of competitions between different strains of X. bovienii.  Here we show that another 
species, Xenorhabdus szentirmaii, produced antibiotics that were active against both gut-derived 
microbes and several species of Xenorhabdus including the well-studied Xenorhabdus 
nematophila. Antibiotics of X. nematophila were not active against X. szentirmaii. In co-cultures 
of wild-type X. szentirmaii and X. nematophila in Grace’s medium that mimics insect hemolymph 
X. nematophila was eliminated. An antibiotic-deficient strain of X. szentirmaii was created by 
inactivation of the ngrA gene. X. nematophila proliferated in co-cultures with the ngrA strain. In 
insects co-infected with wild-type X. szentirmaii and X. nematophila the later was eliminated while 
X. nematophila proliferated in insects co-infected with the ngrA strain indicating that wild-type X. 
szentirmaii produced sufficient levels of antibiotics to inhibit growth of a related competitor. 
MALDI-TOF analysis of hemolymph derived from insects infected with wild-type X. szentirmaii 
revealed the presence of two compounds (m/z 544 and m/z 558) that were absent in hemolymph 
infected with the ngrA strain. To our knowledge, this is the first study to directly demonstrate that 
antibiotics determine the outcome of interspecies competition in a natural host environment. 
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1.0 Introduction 
Little is known about the role of antimicrobials in nature and in the lifecycles of the 
organisms that produce them.  Historically antimicrobial research has been a pursuit to harness 
the potential of antimicrobial agents to prevent and treat disease.  Comparatively few studies 
have investigated the maintenance, evolution, and expression of antimicrobial genes in producer 
organisms or how antimicrobials function in microbial communities in nature.  Traditionally, 
antimicrobials have been perceived as antagonistic molecules that function as weapons employed 
by bacteria in competition for resources (1).  Recent work has argued that in nature, antibiotics 
are mostly produced at subinhibitory concentrations (SIC) and subsequently their true functions 
are actions stimulated by SIC.  The SIC of antibiotics induce shifts in bacterial gene expression 
in vitro (2–7), act as signals that may mediate species interactions (6, 8–11), and cause a range of 
global cellular responses, as all antibiotics exhibit pleiotropic effects (12).  Experimental 
evidence coming from natural systems is lacking to support an antagonistic role or a signaling 
role for antibiotics and further, more rigorous studies are needed.  Most of our current knowledge 
of antimicrobial production comes from studies utilizing highly artificial conditions and 
unnatural growth media.  The organisms are studied under environmental conditions that are 
non-native, thus we are missing data about true phenotype and expression of genes under the 
optimal and natural conditions under which they evolved.  The Xenorhabdus model system is 
uniquely conducive to investigating the evolution and role of antimicrobials in nature. 
Competition for resources and favorable niches is a major driving force of evolution in 
the microbial world.  Weapons employed in this competition include antibiotics, small molecule 
(ie colicins, pyocins) and phage-derived bacteriocins (13, 14).  Acquisition of novel 
antimicrobial genes can confer a competitive advantage to producer organisms.  Production of 
these agents requires a delicate balancing act of being antagonistic to competitors while 
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maintaining conditions that are not overly taxing to self and symbiont partners.  The 
Xenorhabdus model system is a powerful tool for investigating the role of antimicrobials in host-
pathogen and host-symbiont relationships, microbial community dynamics, and the evolution of 
microbial genomes.   
Xenorhabdus species form symbiotic associations with entomopathogenic nematodes of 
the Steinernematidae family (15–17).  These associations are non-obligate mutualisms.  The 
symbiotic species can survive independently of one another under laboratory conditions.  
Cyclical colonization gives rise to the symbiosis.  The Steinernema nematodes reproduce inside a 
diverse array of insects with the help of Xenorhabdus bacteria.  It is in the insect cadaver that the 
juvenile nematode is colonized by Xenorhabdus, which occupies a specialized region of the gut 
called the receptacle (15, 18).  When conditions inside the insect cadaver become limiting, 
unknown signals cause the juvenile nematodes to form an exterior cuticle, sealing the mouth and 
anus, resulting in the non-feeding infective juvenile stage.  Infective juveniles will seek out new 
insect hosts to serve as an environment and nutrient source for reproduction.  They will enter the 
new hosts via openings such as the respiratory spiracles, mouth, and anus.  The infective 
juveniles will then migrate to the midgut and perforate the intestine as they enter the hemocoel, 
creating the opportunity for gut microbiota to be translocated to the hemocoel.  Contact with the 
hemolymph in the hemocoel triggers the degradation of the cuticle and subsequent release of the 
Xenorhabdus bacteria by defecation. In the hemocoel Xenorhabdus transitions to its pathogenic 
phase, suppressing the insect’s innate immune response and producing many biologically 
relevant compounds, including virulence factors (19) and insect toxins (20), which contribute to 
the rapid death of the host.  Following adequate immune suppression the bacteria will reach high 
cell density and release exoenzymes (21) and antimicrobials (22–25).  Exoenzymes such as 
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lipase and hemolysin bioconvert the carcass into a nutrient-rich food source (21) as 
antimicrobials are assumed to suppress competitor growth.  Xenorhabdus bacteria may encounter 
two major types of competitors in the hemocoel, gut microbiota that was translocated when the 
nematode perforated the intestine, and other Xenorhabdus bacteria in the event of co-invasion of 
the insect host by more than one species of Steinernema nematodes.   
 
1.1. Competitors of Xenorhabdus  
Xenorhabdus survival depends on the ability to successfully compete for space and 
resources against diverse bacteria in the hemocoel.  Xenorhabdus produce a plethora of soluble 
antimicrobials and phage-derived bacteriocins to theoretically inhibit the growth of bacterial 
competitors (26). Suppression of competitor growth allows Xenorhabdus to reach sufficient cell 
density to ensure reproductive success of its symbiotic nematode partner, which will carry it on 
to the next nutrient source.  Gut competitors encountered by Xenorhabdus in the hemocoel varies 
with the insect host invaded and include gram-positive and gram-negative bacteria, and fungi 
(27). In the event of co-invasion by more than one nematode, Xenorhabdus may compete with 
other closely related species or strains (28–30).  
There are currently over 20 Xenorhabdus and 50 Steinernema species that have been 
characterized.  Each Steinernema nematode is colonized by only one cognate Xenorhabdus 
species, while a single Xenorhabdus species can colonize more than one Steinernema species.  
For example, X. nematophila strains colonizes three different Steinernema species; S. 
carpocapsae, S. websteri, and S. anatoliense, representing two separate clades (31).  X. bovienii 
strains colonize at least 8 different Steinernema species across three clades (31).   
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Xenorhabdus genomes have evolved to encode a broad collection of diverse compounds 
with antimicrobial activity (32).  Soluble antibiotics are traditionally thought to target species 
unrelated to producer organisms.  The antimicrobials produced by Xenorhabdus are 
predominantly active against unrelated bacteria but have also been shown to inhibit growth of 
related strains of Xenorhabdus and Photorhabdus bacteria (32).  The contribution of these 
antibiotics to competition against related strains is unknown.  Defining the role of soluble 
antibiotics and R-type bacteriocins to inter-species and intra-species competition amongst 
Xenorhabdus strains could re-shape prevailing thought on target specificity of antimicrobial 
weapons. 
 
1.2. Xenorhabdus antimicrobials 
1.2.1. Bacteriocins 
Bacteriocins are generally classified as either soluble proteinaceous antimicrobials 
produced by nearly all surveyed lineages of prokaryotes or phage-derived structures produced by 
a limited number of species (13).  Bacteriocins have been implicated in intra-specific 
competition during times of nutrient limitation (13).  It has been inferred that there is strong 
positive selection acting on enteric bacteriocins (13).   They have traditionally been thought to 
target within a species or closely related species (13).  The soluble bacteriocins of gram-negative 
bacteria are large, proteinaceous structures that can be encoded either on plasmids or on the 
chromosome.  Recombination events between existing gram-negative bacteriocins appear to 
have given rise to new bacteriocins (33–36).  The two methods of killing action that have been 
previously described are pore formation and nuclease activity (34). In contrast to gram-positive 
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bacteriocins, gram-negative bacteriocins have not evolved bacteriocin-specific regulation and 
rely on host regulatory networks. 
The most well-studied proteinaceous bacteriocins are the colicins produced by 
Escherichia coli. They are encoded on plasmids and include toxin, immunity, and lysis genes.  
Their domain structure consists of the central domain that recognizes cell surface receptors and 
constitutes about 50% of the protein, the N-terminal domain whose function is translocation of 
the protein into the target cell, and the remaining portion of the bacteriocin encodes the killing 
domain, immunity region, and immunity binding protein (13).  Consistent with early ideas about 
bacteriophage specificity, colicins have a narrow phylogenetic killing range.  Colicins are 
induced under times of stress and are under control of the SOS regulon.  They can also be 
induced using mitomycin C. Hypotheses surrounding the evolution of colicins are grouped 
around killing modality.  Domain shuffling mediated by recombination is responsible for 
generating new pore-forming colicins (37, 38).  The nuclease colicins are thought to evolve due 
to the action of strong positive selection for novel immunity and killing functions arising from 
mutation (13).  The fitness of the producer strain is increased by the expanded immunity function 
while the novel colicin is capable of killing the ancestral strain. 
Phage-derived bacteriocins encoded by P2-type phage are called R-type bacteriocins. 
Some R-type bacteriocins have a narrow killing range while some have a broad killing range and 
have been suggested as a primary mechanism for mediating microbial diversity (39).  
Mechanisms for mediating microbial diversity were recently described in a study that 
demonstrated a link between R-type bacteriocin production and spatial structuring (40).  In this 
study, sympatric isolates of Xenorhabdus bovienii and X. koppenhoeferi from the same core soil 
sample showed resistance to bacteriocins produced by co-isolates, while being sensitive to 
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bacteriocins produced by conspecifics isolated just a few meters away (37).  This spiteful 
behavior benefits kin of producer strains, promoting evolution of bacteriocins.  The costly act of 
bacteriocin production persists as it provides opportunity for resistance to emerge, creating a 
balance maintenance system in well-mixed populations.  Bacteriocin production and resistance 
mechanisms are energetically costly.  Producer strains may derive little benefit from bacteriocin 
production, since bacteriocin action frees nutrients for kin and non-kin alike. Both producer and 
resistant strains may experience retardation in growth rate and population density compared to 
sensitive strains that did not invest any resources in resistance.  Although sensitive strains may 
initially decrease in number, resistant strains can outcompete the producer strains, thus allowing 
sensitive strains, which do not expend energy or resources on resistance, to grow out and gain an 
advantage.  This tripartite interaction creates a rock, paper, scissors model in which the producer 
strains outcompete sensitive strains, while resistant strains outcompete the taxed producer 
strains, allowing sensitive strains to reemerge and potentially become the dominant population 
(38, 41).  The result of these complex interactions is the maintenance of existing strains and 
propagation of new strains.   
An R-type bacteriocin that has been well characterized is xenorhabdicin of X. nematophila.  
Xenorhabdicin is produced in vitro under non-inducing conditions and can be highly induced by 
the addition of mitomycin C (42).  The R-type bacteriocins produced by X. nematophila have a 
contractile tail sheath, tail tube, baseplate, and tail fibers (39).  Tail fibers are likely to confer 
binding specificity.  It has been previously demonstrated that xenorhabdicin is not expressed in 
strains with insertional disruption of tail fiber or tail sheath genes (14).  Recent investigations 
using these mutants showed that xenorhabdicin is required for interspecies competition (14). 
Xenorhabdicin preparations displayed variable activity against diverse strains of Xenorhabdus 
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and Photorhabdus (14). The killing ability is not correlated with phylogenetic distance. A 
xenorhabdicin-deficient strain was unable to outcompete the sensitive Photorhabdus luminescens 
TT01 species in the natural environment of the insect hemocoel (14).  To date, this represents the 
only assessment of the in vivo contribution of xenorhabdicin to competition, and it has only been 
examined at the genus level.  TT01 does not produce bacteriocins or antibiotics that are active 
against X. nematophila, so the outcome of this competition is completely dependent on the 
xenorhabdicin produced by X. nematophila.  Antibiotics are not a dominant force in competition 
between TT01 and X. nematophila.  However, it has yet to be examined if antibiotics are a 
dominating force in competition with other closely related species or strains. Investigations in X. 
bovienii - S. jollieti mutants deficient in xenorhabdicin production revealed that xenorhabdicin 
increased the competitive advantage of the producer strain, but competitive ability of the mutant 
strain was not completely lost when assayed against other X. bovienii strains in vitro (Forst lab, 
unpublished data).  This was the first time that competition on the strain level had been assessed.  
Subsequent inquiries into the retention of competitive ability led to a novel discovery – soluble 
antibiotics can dominate over bacteriocins in certain competitions between strains of X. bovienii.   
Several questions have yet to be addressed regarding these complex interactions.  We are 
uniquely poised to characterize the contributions of xenorhabdicin to intraspecies competition 
utilizing X. bovienii strains from S. feltiae isolated from different geographic regions, and to 
interspecies competition using X. nematophila and X. szentirmaii.  X. nematophila mutants 
deficient in xenorhabdicin production or NRPS-derived antibiotic production are available to 
elucidate the contributions of xenorhabdicin versus antibiotics. Understanding the contribution of 
xenorhabdicin to intragenus, interspecies, and intraspecies competition can shed light on the 
contribution of bacteriocins to nematode fitness in spatially structured communities.  
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Bacteriocins produced by X. bovienii and X. koppenhoeferi do not target kin, but have activity 
against other strains located meters away (37).  This may be a mechanism for preserving the 
gene pool of kin (37).   Nematodes often travel meters to seek out new insect hosts (43, 28).   It 
is predicted that as distance between the original location increases, relatedness to newly 
encountered strains decreases, and the likelihood of bacteriocin sensitivity increases (44).  
Within the range of nematode movement there is genetic diversity and bacteriocin sensitivity 
amongst strain (44).  With this in mind, it is reasonable to hypothesize that there is a selective 
pressure for the generation of divergent specificity.    
The remnant P2-type clusters of X. nematophila, X. bovienii – S. jollieti, and 
Photorhabdus luminescence TT01 have been previously examined (45).  It is likely that there 
was an ancestral acquisition within each genus followed by subsequent separate evolutionary 
histories (45).  Comparison on the species level between X. nematophila and X. bovienii – S. 
jollieti revealed a high degree of conservation of bacteriocin tail structure genes while main tail 
fiber genes were significantly divergent (45).  In addition to the main tail fiber genes, additional 
truncated tail fiber genes and transposase genes were found within an insert in the region 
flanking funZ between the baseplate assembly and tail structure genes (14).  Insertions in the 
funZ location are common in P2 phage (46).   It is possible that the inserted sequences may have 
been translocated by the transposases encoded within the insert.  While divergence of tail fiber 
genes has been examined at the species level, it remains unexplored at the strain level. 
Genomes are now available for nine strains of X. bovienii derived from nine different 
species of Steinernema nematodes.  Comparative analysis revealed that all nine strains contain an 
ancestrally acquired remnant P2-type phage cluster.  There is a high degree of conservation of 
the structural genes for making the baseplate, tail sheath, and tail tube, suggesting that the 
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remnant P2-type clusters are evolving with the chromosome.  In contrast, the genes encoding the 
main tail fiber are highly divergent. While the baseplate assembly and tail structure genes have 
the same number of amino acids and a high percent identity, the main tail fiber genes differ in 
the number of amino acids and percent identity of the C-terminal region.  Although the C-
terminal region is highly divergent, there is a high degree of conservation of the N-terminal 
region.  Interestingly, in most of the strains there has been an insertional event between the 
baseplate and tail structure genes.  Tail fiber fragment and transposase genes constitute the bulk 
of these insertions.  Previous work in X. bovienii – S. jollieti has revealed that at least one of 
these tail fiber fragment genes is being expressed (Forst lab, unpublished data).  Previous work 
has also shown that the specificity of xenorhabdicin produced by X. nematophila is very different 
from the specificity of the xenorhabdicin produced by X. bovienii – S. jollieti, while the 
resolvable structures and expression patterns of key genes in the remnant clusters are 
homologous (2, 16, Forst lab unpublished data).  Based upon this data, it is reasonable to 
hypothesize that specificity divergence is related to tail fiber divergence. 
If specificity is determined by tail fibers, the C-terminal sequence could be determining 
the evolutionary trajectory of the X. bovienii strains.  Provided that specificity dictates the ability 
to compete, it will also determine niche colonization of the nematode.  Colonization leads to 
geographic isolation and subsequent speciation.  By examining the relationship between tail fiber 
sequence, specificity, and competitive success, we could identify gears that are driving the 
evolutionary machinery of the diverse X. bovienii strains. 
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1.2.2. Xenorhabdus antibiotics 
As much as 7.5% of the X. nematophila genome is dedicated to the production of secondary 
metabolites including antibiotics (47).  X. nematophila produces indole-derived nematophins 
(48), antibacterial peptides (49), and the benzoypyran xenocoumacin (22–24, 50).   Secondary 
metabolite antibiotics are synthesized by non-ribosomal peptide synthetases (NRPS) and 
polyketide synthetases (PKS).  NRPSs and PKSs have several required and optional domains that 
function in tandem to assemble products.  An NRPS/PKS hybrid cluster that includes two NRPS 
genes and three PKS genes produces xenocoumacin (51).  The X. nematophila genome encodes 
seven NRPS and NRPS/PKS gene clusters (including the xenocoumacin cluster) and six 
individual NRPS genes.  It is possible that one or more of these gene clusters encodes a 
secondary metabolite (compounds F and C) that could be responsible for the residual antibiotic 
activity displayed by mutants deficient in xenocoumacin production (52).  Inactivation of the 
ngrA gene, which encodes a 4’phosphopantetheinyl required for active NRPS and PKS enzymes 
(53), eliminated NRPS/PKS secondary metabolite production in X. nematophila.  The ngrA 
mutant is useful in assessing competition in the absence of NRPS/PKS derived antibiotics.  A 
previous study demonstrated that wild-type X. nematophila eliminated the sensitive gut 
competitor S. saprophyticus when co-injected into Manduca sexta larvae, and in co-culture in LB 
broth (27).  In broth culture, S. saprophyticus persisted when co-cultured with the ngrA mutant. 
When S. saprophyticus was co-injected into M. sexta with the ngrA mutant, S. saprophyticus was 
eliminated (27).  X. nematophila may produce ngrA-independent antimicrobial compounds that 
were responsible for the activity against S. saprophyticus. These findings raise the question of 
whether X. nematophila produces inhibitory levels of ngrA-dependent antibiotics during in vivo 
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growth. Previous studies have suggested that secondary metabolites that displayed inhibitory 
activity at higher concentrations in in vitro assays may be produced at sub-inhibitory levels when 
the bacteria grow in their natural environment (12). In this regard, X. szentirmaii, a species that 
produces exceptionally high levels of antibiotic activity in vitro (32), was chosen to address this 
question. 
The X. szentirmaii draft genome sequence is now available (54).  Consistent with other 
sequenced Xenorhabdus genomes, there has been extensive expansion of NRPS genes and 
several candidate clusters may produce antibiotics.  Thus far natural products isolated from X. 
szentirmaii broth cultures include xenofuranones A and B which display no antibacterial or 
antifungal activity (55), and szentiamide, which also displayed no antibacterial or antifungal 
activity but interestingly displayed activity against protists such as Plasmodium falciparum and 
against insect cells (56).  In antibiotic overlay assays and cell-free supernatant assays X. 
szentirmaii displayed strong inhibitory activity against diverse Xenorhabdus species as well as 
competitors isolated from the gut of M. sexta (Forst lab, unpublished data).  The compounds and 
gene clusters responsible for inhibitory activity against microbial competitors have yet to be 
identified.  Given the high level of antibiotic production of X. szentirmaii and its ability to inhibit 
related competitors, it is the ideal bacterium for investigating the role of antibiotics under natural 
competitive conditions. 
 
1.3. Dissertation objectives 
 In this study, we explore the role of R-type bacteriocins and NRPS-derived antibiotics in 
inter-species and intra-species competition across diverse Xenorhabdus strains.  We define the 
relationship between R-type bacteriocin tail fiber sequence and specificity of strains of X. 
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bovienii to determine if killing ability is correlated to phylogenetic distance and if 
xenorhabdicins are being used as weapons in intra-species competition.  Further, we demonstrate 
for the first time that antibiotics are produced in vivo at inhibitory concentrations and are 
required in a competition between two closely related species. 
The first goal of this study is to characterize the genetic diversity of R-type bacteriocin 
tail fiber sequence in strains of the same species of X. bovienii and to assess if there is a 
correlation between sequence similarity and target specificity.  Previous work had shown that the 
xenorhabdicins produced by two different species, X. nematophila and X. bovienii – S. jollieti, 
differed markedly in target specificity (45, Forst lab unpublished data).  Whether xenorhabdicins 
from different strains of the same species exhibit diversity in target specificity had not been 
previously examined. To analyze the relationship between tail fibers and specificity, 
interrelatedness of tail fiber phylogenetic distance and specificity range of xenorhabdicins from 
select strains was assessed.  The sequenced genomes of the X. bovienii strains from S. 
oregonense, S. puntauvense, S. intermedium, S. jollieti, S. feltiae-Florida, S. feltiae-France, S. 
feltiae-moldova, S. krauseii-Quebec, and S. krauseii-Becker Underwood are now available.  
Comparative genomic analysis of phage clusters across X. bovienii strains and X. nematophila as 
a comparative reference species was conducted and P2-like remnant phage clusters were 
identified. Conservation and divergence of major structural proteins of tail fiber and truncated 
tail fiber sequences were assessed.  Select strains of X. bovienii were screened for bacteriocin 
production under induced and uninduced in vitro conditions.  Bacteriocin specificity and activity 
against closely related strains was defined using PEG-precipitated bacteriocin preps.  The role of 
bacteriocins in competition amongst strains of the same species isolated from the same nematode 
was assessed using in vitro assays. 
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The second aim of this study was to determine if NRPS-derived antibiotics are produced 
in vivo at inhibitory concentrations and function as a weapon targeting related and non-related 
natural competitors.  Mutants deficient in NRPS-derived antibiotics (ngrA) and the R-type 
bacteriocin xenorhabdicin (xspS) were created to assess the contribution of each antimicrobial to 
inhibition of biologically relevant competitors under in vitro and in vivo conditions.  Competitors 
displayed sensitivity to both xenorhabdicin and NRPS-derived antibiotics, confirmed by mutant 
analysis.  In vivo competitions in M. sexta revealed that NRPS-derived antimicrobials are 
produced at sufficient concentrations to inhibit a competitor, and the outcome of the competition 
is determined by X. szentirmaii antibiotics. To our knowledge, this is the first study to directly 
demonstrate that antibiotics determine the outcome of interspecies competition in a natural host 
environment. MALDI-TOF mass spectrometry confirmed the presence of two compounds in the 
hemolymph of wild-type infected M. sexta that were absent in the hemolymph of ngrA-infected 
M. sexta supporting the hypothesis that X. szentirmaii antibiotics are produced under natural, in 
vivo conditions. 
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Chapter Two 
 
R-type bacteriocins in related strains of Xenorhabdus bovienii: 
Xenorhabdicin tail fiber modularity and contribution to competitiveness 
 
This chapter is a modified version of the published paper: 
Kristin Ciezki, Kristen Murfin, Heidi Goodrich-Blair, Patricia Stock and Steven A. Forst.  
R-type bacteriocins in related strains of Xenorhabdus bovienii:  Xenorhabdicin tail fiber 
modularity and contribution to competitiveness.  FEMS Microbiol Lett. 2017 Jan;364(1)  
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2.0 Introduction 
Bacteria employ several strategies to compete for resources and favorable niches. 
Interference competition is a direct antagonistic interaction in which organisms produce 
compounds to directly inhibit or kill competitors (1). Antagonistic compounds include small 
antibiotics, proteinaceous molecules such as colicins, and phage-derived bacteriocins (2–4). 
Several lines of evidence have demonstrated that bacteriophages and phage-derived particles can 
determine bacterial community structure and are major drivers of diversity of bacterial 
populations (5, 6). Compared with antibiotics and proteinaceous colicins, the role of phage-
derived bacteriocins in competitive interactions has been less well studied. R-type bacteriocins 
are contractile phage-tail-like structures related to P2 phage encoded in remnant prophage 
clusters composed of tail sheath, tube, baseplate and fiber genes (7).  The conserved N-terminal 
region of the tail fiber interacts with baseplate proteins while the divergent C-terminal end 
determines target-binding specificity (7). While antibiotics generally have a broader spectrum of 
activity, R-type bacteriocins are effective against more closely related species and strains.  
Generation of tail fiber diversity in R-type bacteriocins has been demonstrated in Erwinia 
carotovora (carotovoricin) in which a DNA region encoding the C-terminal fiber module located 
adjacent to the main fiber gene inverts to create two distinct tail fibers (8).  DNA inversion of tail 
fiber genes also occurs in Photorhabdus luminescens, the sister taxon of Xenorhabdus spp. (9). 
Recent investigation of the tail fibers of R-type bacteriocins of the mutualistic bacteria X. 
nematophila and X. bovienii suggested that modules encoding fragments of tail fibers were 
exchanged between the respective species (10). 
Xenorhabdus species form mutualistic associations with soil-dwelling entomopathogenic 
nematodes of the Steinernematidae family (11, 12). Colonized nematodes invade an insect host 
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via natural openings and enter the hemocoel where they release Xenorhabdus into the insect 
hemolymph. The bacteria suppress the insect’s innate immune response and produce antibiotics 
and colicin (xenocin) that inhibit the growth of sensitive gut-derived bacteria that enter the 
hemocoel during nematode invasion (13–16). Insect hosts may also be co-infected with more 
than one species of entomopathogenic nematode (17, 18).  We showed previously that in vivo 
reproduction of aposymbiotic Steinernema carpocapsae (not colonized with its cognate 
symbiont, X. nematophila) was inhibited by a bacterial non-cognate symbiont isolated from 
another entomopathogenic nematode (4). The non-cognate competitor was eliminated and 
nematode reproduction was restored when wild-type X. nematophila was co-injected into the 
host. A mutant strain in which the tail sheath gene (xnpS1) of the remnant P2 phage cluster 
(xnp1) was inactivated did not restore nematode reproduction. X. nematophila also possesses an 
intact P2 phage cluster of X. nematophila that is neither expressed nor involved in interspecies 
competition. Similarly, a remnant P2 cluster (xbp1) in the X. bovieni strain isolated from 
Steinernema jollieti was expressed and required for xenorhabdicin production (10). These results 
suggest that xenorhabdicins are involved in the defensive mutualistic association between 
Steinernema nematodes and their Xenorhabdus symbionts.  
 Since strains of the same species are likely to occupy overlapping ecological niches, 
competition between strains is predicted to occur on a biological scale (6).  Xenorhabdicin 
producer and non-producer isolates of X. bovienii were recently obtained from naturally 
coexisting Steinernema nematodes (19).  Xenorhabdicin activity was implicated in conferring a 
competitive in vivo growth advantage to the producer cells but not the non-producer cells co-
injected with a sensitive competitor.  Recent genome sequencing of nine strains of X. bovienii 
isolated from six different species of Steinernema nematodes established genetic diversity at the 
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strain level (20). Further, in experiments using these strains an inverse correlation was noted 
between fitness of a S. feltiae-X. bovienii complex and phylogenetic distance of the test X. 
bovienii strain from the native symbiont of the nematode. Overall these data suggest that 
diversity at the strain level may underlie specific interactions with distinct nematodes to help 
maintain symbiotic associations (21).  Since xenorhabdicins may provide fitness benefits to 
producer strains we examined remnant P2-like phage clusters and the C-terminal region of tail 
fibers in draft genomic sequences of nine X. bovienii strains.  
 
2.1. Materials and methods 
2.1.1. Bacterial strains and growth conditions 
Strains used in this study are listed in Table S1.  All strains were grown in lysogeny broth 
(LB) at 30°C.  Green fluorescent protein (GFP)-producing X. bovienii strains were constructed as 
previously published (22, 23). Using the plasmid mini-Tn7-KSGFP (24), the GFP-encoding gene 
was introduced into the attTn7 site of strains Xb-Sf-FL, Xb-Sf-FR, and Xb-Sf-MD to produce 
GFP-producing strains. 
 
2.1.2. P2-type prophage bioinformatics analysis 
The xenorhabdicin-encoding P2-type prophage clusters were identified using the BlastP 
algorithm in the MaGe MicroScope platform. Genes were annotated according to the results of 
the BlastP algorithms.  The EMBL Clustal Omega and NCBI Align Sequences Protein Blast 
algorithms were used to identify conserved tail fiber sequences and calculate percent identity. 
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Table S1.  Bacterial strains used in this study. 
 
Strain 
Steinernema 
nematode host Geographic location Source 
Genome Accession 
Number 
X. nematophila 
19061 Xn-Sc 
S. carpocapsae USA Laboratory stock [EMBL:PRJNA13400] 
FN887742* 
X. nematophila 
19061::ΔxnpS1 
S. carpocapsae USA Laboratory stock  
X. bovienii 
Xb-Sf-FL 
S. feltiae Florida, USA P. Stock [EMBL:PRJEB4320]* 
X. bovienii 
Xb-Sf-FR 
S. feltiae France P. Stock [EMBL:PRJEB4319]* 
X. bovienii 
Xb-Sf-MD 
S. feltiae Moldova P. Stock [EMBL:PRJEB4321] 
X. bovienii 
Xb-Si 
S. intermedium North Carolina, USA P. Stock [EMBL:PRJEB4327]* 
X. bovienii 
Xb-Sj 
S. jollieti Monsanto  [EMBL:PRJEB4326]* 
X. bovienii 
Xb-Sj-2000 
S. jollieti Monsanto  [EMBL:FN667741] 
X. bovienii 
Xb-Sk-BU 
S. kraussei BeckerUnderwood P. Stock [EMBL:PRJEB4325] 
X. bovienii 
Xb-Sk-CA 
S. kraussei Quebec, CA P. Stock [EMBL:PRJEB4324]* 
X. bovienii 
Xb-So 
S. oregonense Oregon, USA P. Stock [EMBL:PRJEB4323]* 
X. bovienii 
Xb-Sp 
S. puntauvense Costa Rica P. Stock [EMBL:PRJEB4322]* 
X. bovienii  
Xb-Sf-FL-GFP 
S. feltiae Florida, USA H. Goodrich - Blair  
X. bovienii  
Xb-Sf-FR-GFP 
S. feltiae France H. Goodrich - Blair  
X. bovienii  
Xb-Sf-MD-GFP  
S. feltiae Moldova H. Goodrich - Blair  
* From Murfin et al,. 2015a
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2.1.3. Bacteriocin-enriched preparations  
LB (100 mL) subcultures inoculated with a 50-fold dilution of overnight cultures were 
grown to an OD600= 0.3-0.4 and induced with 5 µg/mL mitomycin C for 15 hours.  RNase A and 
DNase I were added to a final concentration of 1 µg/mL each and cultures were incubated at 37° 
for 30 minutes.  Cellular debris was removed by centrifugation and supernatants were sterile 
filtered.  Bacteriocin-enriched fractions were obtained by precipitation at 4°C for 2 hours with 
polyethylene glycol 8000 (10% w/v final concentration) and NaCl (1M final concentration).  
Bacteriocin-enriched fractions were harvested by centrifugation at Rmax of 13,776 x g at 4°C for 
15 minutes, resuspended in 3 ml LB, and centrifuged again for 5 minutes.  Supernatants 
containing xenorhabdicins were sterile filtered and stored at 4°C. For protein analysis of 
bacteriocin-enriched fractions 300 µL aliquots were ultracentrifuged at Rmax of 287,582 x g at 
4°C for 15 minutes, pellets were resuspended in 40 µL of Laemmli buffer and 3-6 µL were 
loaded on a 8-16% PAGE gel (Genscript).  For transmission electron microscopy 
ultracentrifuged pellets were resuspended in 50 mM Tris-HCl (pH 8.7).  5µL was placed on grids 
and negatively stained with 0.8% phosphotungstate for 2 minutes.  The samples were examined 
using a Hitachi H-600 transmission electron microscope operated at 75 kV.   
 
2.1.4 Microplate assay of xenorhabdicin activity 
Subcultures (250 µL of overnight culture added to 5 mL LB) were grown to an OD600 = 
0.5 - 0.6.  Assays contained 100 µL of diluted subculture (1200-fold) and 50 µL of 
xenorhabdicin-enriched preparations in a 96 well plate and incubated for 24 hours.  Percent 
inhibition was calculated by comparing OD600 of control cultures versus cultures treated with 
xenorhabdicin-enriched fractions. 
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2.1.5. In vitro competition assays 
Subcultures of wild-type and GFP-labeled strains (250 µL of overnight culture added to 5 
mL of LB) were grown to mid-exponential phase.  Cultures were normalized to an OD600 = 0.25 
and 250 µL of normalized cells were used to inoculate 5 ml of LB broth for control and 
competition cultures. Equal volumes (125 µL) of each competitor were used in competitions.  
Colony forming units per mL at 0 and 24 hours were determined by dilution in Grace’s insect 
medium and plating on LB agar.  Competition experiments for both marked and unmarked 
strains were performed three times. Statistical significance was calculated by unpaired t-tests 
using GraphPad QuickCalcs. 
 
2.2. Results and Discussion 
2.2.1. Remnant P2-like prophage clusters in X. bovienii strains 
 While xenorhabdicin tail fibers of different species have been analyzed previously (10) 
comparison of tail fibers from different strains of the same species had not been examined.  Here 
we analyze remnant P2-like prophage clusters in the draft genomes of nine strains of X. bovienii 
derived from 6 different Steinernema nematodes (Table S1). The organization of the primary 
structural genes between gene X and the T1 tube gene is identical in all strains (Fig. 1). The 
respective baseplate (V-I), sheath (S1) and tube (T1) proteins are highly conserved sharing >98% 
amino acid sequence identity (Fig 1, Tables S2 and S3). Other prophage proteins such as 
endopeptidase (enp) share approximately 90% amino acid identity. CI regulatory genes are 
present upstream of gene X in all of the P2-like prophage clusters (not shown). Additional 
conserved phage genes (purple arrows) and hypothetical genes (white arrows) are present 
between xbpH1 and xbpS1 (H1-S1 region). Finally, the sequences of the remnant P2-type  
  
27 
 
 
Figure 1. Remnant P2-type prophage of X. bovienii strains. Open reading frames are classified 
by color: tail synthesis structural proteins (purple), highly conserved unknown proteins (gray), 
lysis genes (yellow), truncated tail fibers (light green), transposases (pink), and other 
uncharacterized prophage encoded ORFs (white). The remnant prophage clusters were divided 
into two classes based on difference of the respective H1 tail fibers. A 210 amino acid sequence 
was absent in Class I fibers and was present in Class II fibers (see Fig 3). Open reading frames are 
not drawn to scale. P2-type prophage clusters were identified using XbpS1 of X. bovienii SS2004 
as the query sequence and the MaGe platform 
 (www.genoscope.cns.fr/agc/microscope/home/index.php).  
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Table S2.  Percent identity of xenorhabdicin-encoding proteins as compared to Xb-Sj. 
 
 
X unk lys enp V W J I S1 T1 
Class I 
          
Xb-Sj 100 100 100 100 100 100 100 100 100 100 
Xb-Sf-FL 92.5 97.8 96.1 90.5 99.1 99.1 98.7 99.5 99.5 100 
Xb-Sf-FR 92.5 97.8 96.1 90.5 99.1 99.1 98.7 99.5 99.5 100 
Xb-So 98.5 97.8 93.9 90.4 97.2 99.1 99.0 99.5 99.7 100 
Xb-Sk-CA 94.0 87.9 96.1 90.4 99.5 99.1 99.7 99.0 99.7 100 
Xb-Sp 92.5 95.6 96.1 90.5 99.5 99.1 98.3 99.5 99.7 100 
Xb-Sk-BU 92.5 97.8 96.7 89.9 99.1 98.3 99.0 99.0 99.5 99.4 
           
Class II 
          
Xb-Si 97.0 98.9 95.5 89.9 99.1 99.1 99.3 100 99.7 100 
Xb-Sf-MD 92.5 96.7 96.1 90.5 99.1 99.1 98.7 99.5 99.7 100 
           
Xn-Sc 88.1 80.2 - 77.4 95.3 91.3 94.0 89.1 93.6 97.7 
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Table S3.  Number of amino acid residues present in xenorhabdicin-encoding genes. 
 
 
X unk lys enp V W J I S1 T1 
Class I 
          
Xb-Sj 68 92 180 169 212 116 303 203 391 173 
Xb-Sf-FL 68 92 180 167 212 117 303 203 391 173 
Xb-Sf-FR 68 92 180 167 212 117 303 203 391 173 
Xb-So 68 92 180 167 212 117 303 203 391 173 
Xb-Sk-
CA 68 92 180 167 212 117 303 203 391 173 
Xb-Sp 68 92 180 173 212 117 303 203 391 173 
Xb-Sk-
BU 68 92 180 167 212 117 303 203 391 173 
           
Class II 
          
Xb-Si 68 92 180 173 212 117 303 203 391 173 
Xb-Sf-
MD 68 92 180 167 212 117 303 203 391 173 
           
Xn-Sc 68 88 - 179 212 116 303 203 391 173 
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prophage of the Xb-Sj draft genome and the complete Xb-Sj-2000 (25) genome were identical 
providing evidence that the P2-type prophages of the nine draft genomes were accurately 
sequenced.  
The H1-S1 regions in all strains except Xb-Sk-BU contain a variable number of genes 
that encode truncated tail fiber fragments (F) that share similarity with various regions of tail 
fiber genes present in the remnant P2-like prophages of X. bovienii strains. Transposon genes (T) 
are present in several of the H1-S1 regions suggesting that the accumulation of fiber fragments 
may occur via lateral transfer by transposition.  
 
2.2.2. Comparison of the tail fiber fragments in the xbpH1-xbpS1 region 
 To assess the generation of tail fiber diversity in different strains of X. bovienii we 
analyzed the H1-S1 region of three X. bovienii strains obtained from Steinernema feltiae 
nematodes isolated from different geographic locations (Fig 2).  The Xb-Sf-FR and Xb-Sf-FL 
strains and their respective nematode partners belong to the same clades while the Xb-Sf-MD 
strain is more closely related to X. bovienii from S. puntauvense (21).  We showed previously 
that R-type bacteriocins were induced by mitomycin C in the Xb-Sf-FL strain (10).  
Fig 2 shows that genes 28 and 29 in Xb-Sf-FL are identical to genes 10 and 11 in Xb-Sf-
FR and genes 25, 26 and 27 of Xb-Sf-FL are identical to genes 8, 7 and 6 of Xb-Sf-FR. In 
contrast, gene 30 in Xb-Sf-FL was not similar to any of the genes in the H1-S1 region of Xb-Sf-
FR while the sequence between amino acids 15-357 of gene 30 was 100% identical to the C-
terminal 341 amino acids of the tail fiber of Xb-Sf-FR (gene 12).  Similarly, gene 9 in Xb-Sf-FR 
is 100% identical to the C-terminal 371 amino acids of XbpH1 of Xb-Sf-FL. These findings 
suggest that divergence of the tail fibers of these two strains may have been generated by   
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Figure 2. Mosaic modularity of XbpH1 tail fibers of three Xb-Sf strains. The xbpH1-xbpS1 
intergenic regions of Xb-Sf-FR, Xb-Sf-FL, and Xb-Sf-MD are shown. Numbers associated with 
each open reading frame represent gene labels derived from the respective draft genomes: Xb-Sf- 
FR (310006-3100012); Xb-Sf-FL (2380124-2380130); Xb-Sf-MD (1680019-1680022). Colors of 
the open reading frame indicate modules containing identical amino acid sequences.translocation 
and inversion of genes 28-30 of Xb-SF-FL such that the tail fragment gene 30 replaced the C-
terminal region of the tail fiber (gene 24) producing the tail fiber of Xb-Sf-FR (gene 12). 
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translocation and inversion of genes 28-30 of Xb-SF-FL such that the tail fragment gene 30 
replaced the C-terminal region of the tail fiber (gene 24) producing the tail fiber of Xb-Sf-FR 
(gene 12). 
The H1-S1 region in Xb-Sf-MD contains three genes, one of which (gene 20) is 79% 
identical to both gene 7 in Xb-Sf-FR and gene 26 in Xb-Sf-FL. The C-terminal region of XbpH1 
in Xb-Sf-MD is unique and is not similar to the fiber fragments in either Xb-Sf-FR or Xb-Sf-FL. 
Thus, the H1-S1 cassette of Xb-Sf-MD was likely acquired independently and is consistent with 
the more distant phylogenetic relationship of Xb-Sf-MD relative to the Xb-Sf-FL and Xb-Sf-FR 
strains.  
 
2.2.3. Mosaic organization of submodules in the XbpH1 tail fibers 
 The length of the H1 tail fibers in the nine strains is highly variable ranging from 485 
(Xb-Sf-BU) to 922 (Xb-Si) amino acids (Fig 3).  Six of the tail fibers contain unique sequences 
(white) not found in other tail fibers. Comparison of the amino acid sequence of the XbpH1 tail 
fibers revealed that the N-terminal 310 amino acids (black) are identical while the C-terminal 
regions consist of several different submodules and are highly divergent (Fig 3). A conserved 13 
amino acid sequence (orange box) is located at the junction of the N-terminal domain and the C-
terminal modules in all X. bovienii tail fibers suggesting it is involved in recombination events 
that generate diversity in the C-terminal domain. Extensive submodule exchange is apparent in 
the C-terminal domain. For example, the submodule between amino acids 401 and 627 of 
XbpH1 of Xb-Sf-FL (purple) is also present in the C-terminal region of Xb-Sj (Fig 3, Table S4). 
Likewise, a 123-residue submodule at the C-terminus of the tail fiber (brown) is also present in 
the tail fibers of Xb-Sk-CA and Xb-Si (Fig 3, Table S4). Similarly, the C-terminus of XbpH1 of 
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Figure 3. Submodules of the H1 tail fibers in the nine X. bovienii strains. Highly conserved 
submodules found in more than one strain are indicated by identical colors. All X. bovienii strains 
and X. nematophila 19061 share a conserved N-terminal region (black) followed by a linker region 
(orange) of variable size. Class II and X. nematophila fibers share an extended conserved N-
terminal region (blue). Unique regions of tail fibers are shown in white. The various submodules 
and unique regions are drawn to scale.S4.  Number of amino acids and percent identity of H1 tail 
fiber sequence modules as compared to X. bovienii – S. feltiae strains. 
  
  
34 
 
Table S4.  Number of amino acids and percent identity of H1 tail fiber sequence modules as 
compared to X. bovienii – S. feltiae strains. 
 
 Xb-Sf-FR 
 Pink Yellow 
 % identity Amino acids % identity Amino acids 
Xn-Sc 78 193 83 53 
     
 Xb-Sf-FL 
 Purple Brown 
 % identity Amino acids % identity Amino acids 
Xb-Sj 74 167   
Sb-Sk-CA   82 123 
Xb-Si   82 123 
     
 Xb-Sf-MD 
 Red Light blue 
 % identity Amino acids % identity Amino acids 
Xb-Sk-CA 68 118   
Xb-Si 66 121   
Xb-Sj   54 150 
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Xb-Sf-FR consists of a submodule of 193 amino acids (pink) into which a 53-residue submodule 
(yellow) has been inserted (Fig 3).  These submodules are also present in the C-terminal region 
of XnpH1 of X. nematophila (Fig 3, Table S4). The XnpH1 fiber possesses an approximately 210 
amino acid submodule (blue) that is attached to the conserved N-terminal domain (black). This 
submodule is also present in the fibers of Xb-Sf-MD and Xb-Si (Class II fibers). The conserved 
13-amino-acid sequence (orange) identified in Class I fibers (see above) is also present at the 
junction of the N-terminal domain (black) and 210-amino-acid submodule (blue) in Class II 
fibers. Finally, the tail fiber of Xb-Sf-MD possesses a 120 amino acid submodule (red) also 
present in the fibers of Xb-Sk-CA and Xb-Sj and a 150 amino acid submodule (light blue) found 
in the fiber of Xb-Sj (Table S4).  Thus, the diversity of tail fiber sequence of X. bovienii strains 
isolated from distinct S. feltiae nematodes is apparently the result of extensive DNA transfer that 
generated unique mosaic organizations of submodules. These findings are reminiscent of gene 
mosaics of tail fibers of DNA bacteriophage in which horizontal gene transfer and DNA 
inversion were responsible for exchange of host-range determinants (26). Another example of 
variation of C-termini domains attached to conserved core N-terminal domains is evidenced in 
the Rhs proteins encoded in enterobacterial genomes. Homologous recombination of existing C-
termini domains with other alternative domains carried on episomes was proposed as the 
mechanism driving C-termini variation (27).   
 
2.2.4. Analysis of xenorhabdicin activity 
The competitive outcome between X. bovienii strains is correlated with the relative 
activity and level of production of the xenorhabdicins of the respective strains (19). Since the 
activity of xenorhabdicins of different isolates of the same strain of Xenorhabdus has not been 
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previously analyzed we assessed the relative activity of xenorhabdicins from the three isolates of 
Xb-Sf. To this aim phage tail-enriched fractions were prepared from cell cultures induced with 
mitomycin C. The optical density of cultures 15 h after addition of mitomycin C was markedly 
lower than uninduced cultures indicating that cells had lysed due to prophage induction 
(unpublished data). The same amount of phage tail sheath protein (XbpS1) was present in the 
phage tail-enriched fractions of Xb-SF-FL (Fig 4, lane 3) and Xb-Sf-FR (lane 5). The amount of 
XbpS1 was similar in the phage tail-enriched fraction of Xb-Sf-MD (lane 7) though it migrated 
to a lower apparent molecular weight. XbpS1 was barely detectable in the uninduced 
preparations (lanes 4, 6, 8). Analysis of the phage tail-enriched fractions by transmission electron 
microscopy confirmed that R-type bacteriocins were present in the induced phage tail-enriched 
preparations of Xb-Sf-FL and Xb-Sf-FR while phage tail-enriched preparations Xb-Sf-MD 
appeared to have fewer typical R-type bacteriocins and more than one type of phage tail structure 
(Fig S1). Together, these findings indicate that R-type bacteriocins were induced by mitomycin 
C in the Xb-Sf strains. 
We tested the growth inhibiting activity of each xenorhabdicin preparation against the 
two other strains (Table 1). Each xenorhabdicin displayed a different pattern of activity 
consistent with the high degree of variability of the C-terminal tail fiber regions. Xb-Sf-FR 
xenorhabdicin was highly active against Xb-Sf-MD that belongs to a different clade than Xb-Sf-
FR and Xb-Sf-FL (21), but was inactive against the more closely related Xb-Sf- FL strain. The 
Xb-Sf-MD xenorhabdicin displayed the same moderate activity against both Xb-Sf-FR and Xb 
Sf-FL. Finally, xenorhabdicin from Xb-Sf-FL was inactive against the other Xb-Sf strains. 
  
  
37 
 
 
 
Figure 4.  Analysis of tail sheath (XbpS1) levels in bacteriocin-enriched fractions of Xb-Sf 
isolates.  Bacteriocin preparations from mitomycin C-induced (lanes 3, 5, 7) and uninduced (lanes 
4, 6, 8) cultures were applied onto a 8%-16% PAGE gel. A xenorhabdicin fraction from wild-type 
X. nematophila (lane 1) and an xnpS1-mutant strain (lane 2) was used to mark the position of 
XbpS1 (43.5 kDa). Lanes 3 and 4, Xb-Sf-FL; lanes 5 and 6, Xb-Sf-FR; lanes 7 and 8, Xb-Sf-MD. 
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Figure S1. Transmission electron microscopic analysis of bacteriocin-enriched fractions of 
Xb-Sf isolates.  Fractions were prepared as described in Methods.  Panel A.  Xb-Sf-FL.  Panel 
B.  Xb-Sf-FR.  Panel C.  Xb-Sf-MD.  Arrows point to different R-type bacteriocin structures; 
extended sheath (Ex), contracted sheath (Cr), and empty sheath (Em).  The number of bacteriocin 
particles per micrograph is representative of the relative concentration produced by each 
strain.  Size bars represent 200 nm. 
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 Table 1.  Inhibitory activity of xenorhabdicin from Xb-Sf strains.   
 
 Xenorhabdicin producer 
 Xb-Sf-FR Xb-Sf-FL Xb-Sf-MD 
Target strain    
Xb-Sf-FR - 3 (1.9) 39 (3.4) 
Xb-Sf-FL 0 (0.3) - 39 (4.4) 
Xb-Sf-MD 89 (2.1) 3 (2.4) - 
 
Values represent mean percent inhibition and standard error in parentheses. 
Data is derived from 4 experiments. 
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2.2.5. In vitro competition between Xb-Sf strains 
 To determine whether the different levels of xenorhabdicin activity described above 
correlated with competitive success of the producer strain we carried out pairwise co-culture 
experiments. To distinguish between the Xb-Sf strains a GFP-encoding gene was inserted into 
the respective chromosomes and competitions were carried out with a GFP-marked strain and an 
unmarked strain. Inverse competitions were also conducted in which the strain marked with GFP 
was reversed. The outcome of the competition was determined by counting the number of 
fluorescent and non-fluorescent unmarked colonies using fluorescent and light microscopy. 
Before performing the competition experiments we confirmed that the individual growth rates of 
the GFP and unmarked versions of each strain, and the growth rates of each strain relative to the 
other strains, were comparable (unpublished data). 
 The strong inhibition of the MD strain by the xenorhabdicin of the FR strain suggested 
the latter would display a competition advantage over the MD strain. To test this prediction the 
strains were co-cultured for 24 h and dilution plated. In the competition between GFP-MD and 
the unmarked FR strains the MD strain was completely eliminated (Fig 5A). In the inverse 
competition the GFP-FR strain outcompeted but did not completely eliminate the unmarked MD 
strain (Fig 5B; see below). Thus, the high level of activity of the FR xenorhabdicin in the 
bacteriocin assay correlated with the ability to outcompete the MD strain. In contrast, the MD 
strain was resistant to the xenorhabdicin of the FL strain while the MD xenorhabdicin 
moderately inhibited the FL strain. Based on the relative activity of the respective 
xenorhabdicins the MD was predicted to outcompete the FL strain. Unexpectedly, the GFP-FL 
strain outcompeted but did not eliminate the MD strain (Fig 5C). In the inverse competition the 
GFP-FL strain was able to outcompete the MD strain (Fig 5D) although the unmarked MD strain 
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Figure 5.  In-vitro pairwise co-culture competitions in LB broth amongst X.bovienii- S.feltiae  
strains.  Competition outcomes at 24 hours were determined by dilution plating.  Error bars show 
standard errors of the means.  Asterisks indicate statistically significant differences (P<0.05) as 
calculated by unpaired t-tests using the GraphPad QuickCalcs t-test calculator. Each competition 
was repeated at least four times. 
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 grew to a higher level than in the GFP-MD versus FR competition (Fig 5C). These findings 
suggest that xenorhabdicin was not a primary determinant in the outcome of this competition and 
that the FL strain produced antagonistic factors that were active against the MD strain.  
 The more closely related FR and FL strains were shown to be resistant to each other’s 
xenorhabdicin (Table 1) suggesting that neither would have a competitive advantage when 
grown together. In co-cultures with the GFP-FL and unmarked FR strains neither strain was 
inhibited although the FR strain grew to slightly higher levels (Fig 5E) while the unmarked FL 
strain grew to slightly levels in co-cultures with the GFP-FR strain (Fig 5F). Therefore the slight 
differences in growth in co-cultures with the closely related FR and FL strains were apparently 
not due to antagonistic factors but rather to fitness costs imposed by the expression of GFP. The 
apparent fitness cost was also discernible in the competition with the MD strain in which the 
marked FR and FL strains inhibited growth of the MD strain to a lesser extent than the unmarked 
strains.    
 
2.3. Conclusions 
 We show that modular exchange and DNA inversion generate diversity and specificity in 
xenorhabdicin tail fibers in related strains of X. bovienii.  Xenorhabdicins are primary 
determinants of competitive success between some strains of X. bovienii while different 
antagonistic factors may determine the competitive outcome between other strains. Under natural 
biological conditions the level of expression and activity of the various antagonistic factors, 
relative proportion of each competitor, differences in in-host growth rate and other variables 
interact to influence the competitive outcome. These interactions may in turn affect maintenance 
of community diversity (19).  
  
43 
 
2.4. Acknowledgements 
This study was supported by a collaborative grant from the National Science Foundation 
to S.F. (IOS-0919912), H.G.-B. (IOS-0920631) and S.P.S. (IOS-0919565). 
  
  
44 
 
2.5. References 
1.  Hibbing ME, Fuqua C, Parsek MR, Peterson SB. 2010. Bacterial competition: surviving 
and thriving in the microbial jungle. Nat Rev Microbiol 8:15–25. 
2.  Riley MA, Wertz JE. 2002. Bacteriocins: Evolution, Ecology, and Application. Annu Rev 
Microbiol 56:117–137. 
3.  Clardy J, Fischbach M a, Currie CR. 2009. Primer The natural history of antibiotics. Curr 
Biol 19:437–441. 
4.  Morales-Soto N, Forst SA. 2011. The xnp1 P2-like tail synthesis gene cluster encodes 
xenorhabdicin and is required for interspecies competition. J Bacteriol 193:3624–3632. 
5.  Weinbauer MG, Rassoulzadegan F. 2004. Are viruses driving microbial diversification 
and diversity? Environ Microbiol 6:1–11. 
6.  Hawlena H, Bashey F, Lively CM. 2012. Bacteriocin-mediated interactions within and 
between coexisting species. Ecol Evol 2:2521–2526. 
7.  Nakayama K, Takashima K, Ishihara H, Shinomiya T, Kageyama M, Kanaya S, Ohnishi 
M, Murata T, Mori H, Hayashi T. 2000. The R-type pyocin of Pseudomonas aeruginosa is 
related to P2 phage, and the F-type is related to lambda phage. Mol Microbiol 38:213–
231. 
8.  Nguyen HA, Tomita T, Hirota M, Kaneko J, Hayashi T, Kamio Y. 2001. DNA inversion 
in the tail fiber gene alters the host range specificity of carotovoricin Er, a phage-tail-like 
bacteriocin of phytopathogenic Erwinia carotovora subsp. carotovora Er. J Bacteriol 
183:6274–6281. 
9.  Gaudriault S, Thaler J-O, Duchaud E, Kunst F, Boemare N, Givaudan A. 2004. 
Identification of a P2-related prophage remnant locus of Photorhabdus luminescens 
encoding an R-type phage tail-like particle. FEMS Microbiol Lett 233:223–231. 
10.  Morales-Soto N, Gaudriault S, Ogier JC, Thappeta KRV, Forst S. 2012. Comparative 
analysis of P2-type remnant prophage loci in Xenorhabdus bovienii and Xenorhabdus 
nematophila required for xenorhabdicin production. FEMS Microbiol Lett 333:69–76. 
11.  Forst S, Clarke DJ. 2002. Bacteria-nematode symbiosis, p. 57–77. In Entomopathogenic 
nematology. 
12.  Herbert EE, Goodrich-Blair H. 2007. Friend and foe: the two faces of Xenorhabdus 
nematophila. Nat Rev Microbiol 5:634–646. 
13.  Hwang J, Park Y, Kim Y, Hwang J, Lee D. 2013. An entomopathogenic bacterium, 
xenorhabdus nematophila, suppresses expression of antimicrobial peptides controlled by 
toll and imd pathways by blocking eicosanoid biosynthesis. Arch Insect Biochem Physiol 
83:151–169. 
14.  Singh J, Banerjee N. 2008. Transcriptional analysis and functional characterization of a 
gene pair encoding  iron-regulated xenocin and immunity proteins of Xenorhabdus 
nematophila. J Bacteriol 190:3877–3885. 
  
45 
 
15.  Reimer D, Luxenburger E, Brachmann AO, Bode HB. 2009. A new type of pyrrolidine 
biosynthesis is involved in the late steps of xenocoumacin production in Xenorhabdus 
nematophila. Chembiochem 10:1997–2001. 
16.  Singh S, Orr D, Divinagracia E, McGraw J, Dorff K, Forst S. 2015. Role of secondary 
metabolites in establishment of the mutualistic partnership between Xenorhabdus 
nematophila and the entomopathogenic nematode Steinernema carpocapsae. Appl Environ 
Microbiol 81:754–764. 
17.  EE L. 2002. Behavioural ecology, p. 205–223. In Gaugler R (ed.), Entomopathogenic 
Nematology. CABI Publishing, Wallingford, UK. 
18.  Půža V, Mráček Z. 2009. Mixed infection of Galleria mellonella with two 
entomopathogenic nematode (Nematoda: Rhabditida) species: Steinernema affine benefits 
from the presence of Steinernema kraussei. J Invertebr Pathol 102:40–43. 
19.  Bashey F, Young SK, Hawlena H, Lively CM. 2012. Spiteful interactions between 
sympatric natural isolates of Xenorhabdus bovienii benefit kin and reduce virulence. J 
Evol Biol 25:431–437. 
20.  Murfin KE, Whooley AC, Klassen JL, Goodrich-Blair H. 2015. Comparison of 
Xenorhabdus bovienii bacterial strain genomes reveals diversity in  symbiotic functions. 
BMC Genomics 16:889. 
21.  Murfin KE, Lee MM, Klassen JL, McDonald BR, Larget B, Forst S, Stock SP, Currie CR, 
Goodrich-Blair H. 2015. Xenorhabdus bovienii strain diversity impacts coevolution and 
symbiotic maintenance with Steinernema spp. nematode hosts. MBio 6:e00076 
22.  Sugar DR, Murfin KE, Chaston JM, Andersen AW, Richards GR, deLéon L, Baum JA, 
Clinton WP, Forst S, Goldman BS, Krasomil-Osterfeld KC, Slater S, Stock SP, Goodrich-
Blair H. 2012. Phenotypic variation and host interactions of Xenorhabdus bovienii SS-
2004, the entomopathogenic symbiont of Steinernema jollieti nematodes. Environ 
Microbiol 14:924–939. 
23.  Chaston JM, Murfin KE, Heath-Heckman EA, Goodrich-Blair H. 2013. Previously 
unrecognized stages of species-specific colonization in the mutualism between 
Xenorhabdus bacteria and Steinernema nematodes. Cell Microbiol 15:1545–1559. 
24.  Teal TK, Lies DP, Wold BJ, Newman DK. 2006. Spatiometabolic stratification of 
Shewanella oneidensis biofilms. Appl Environ Microbiol 72:7324–7330. 
25.  Chaston JM, Suen G, Tucker SL, Andersen AW, Bhasin A, Bode E, Bode HB, 
Brachmann AO, Cowles CE, Cowles KN, Darby C, de Léon L, Drace K, Du Z, Givaudan 
A, Herbert Tran EE, Jewell KA, Knack JJ, Krasomil-Osterfeld KC, Kukor R, Lanois A, 
Latreille P, Leimgruber NK, Lipke CM, Liu R, Lu X, Martens EC, Marri PR, Médigue C, 
Menard ML, Miller NM, Morales-Soto N, Norton S, Ogier JC, Orchard SS, Park D, Park 
Y, Qurollo BA, Sugar DR, Richards GR, Rouy Z, Slominski B, Slominski K, Snyder H, 
Tjaden BC, van der Hoeven R, Welch RD, Wheeler C, Xiang B, Barbazuk B, Gaudriault 
S, Goodner B, Slater SC, Forst S, Goldman BS, Goodrich-Blair H. 2011. The 
Entomopathogenic Bacterial Endosymbionts Xenorhabdus and Photorhabdus: Convergent 
Lifestyles from Divergent Genomes. PLoS One 6:e27909 
  
46 
 
26.  Sandmeier H. 1994. Acquisition and rearrangement of sequence motifs in the evolution of 
bacteriophage tail fibres. Mol Microbiol. 12:343-50 
27.  Jackson AP, Thomas GH, Parkhill J, Thomson NR. 2009. Evolutionary diversification of 
an ancient gene family (rhs) through C-terminal displacement. BMC Genomics 10:584. 
 
  
  
47 
 
Chapter Three 
 
Antibiotics determine the outcome of competition between Xenorhabdus 
species in a natural host environment 
 
This chapter is a modified version of the submitted paper: 
 
Kristin Ciezki, Shama Mirza and Steven Forst. 2017. Antibiotics determine the outcome of 
competition between Xenorhabdus species in a natural host environment. Appl. Environ. 
Microbiol. 
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3.0 Introduction  
Microorganisms exist in diverse communities in almost every natural habitat. To compete 
for space, nutrients, and other resources, microbes employ an array of strategies to gain a 
competitive advantage (1).  One strategy, interference competition, involves the production of a 
wide range of antagonistic compounds and molecules to inhibit growth of related and non-related 
species. Bacteria can produce several classes of antagonistic agents. Small molecule antibiotics 
usually possess broad spectrum activity that inhibit growth of more distantly related species. 
While antibiotics have been extensively exploited as therapeutic agents, their role in interspecies 
competition in ecological settings remains poorly understood (2–4). R-type bacteriocins are 
phage-tail-like structures that suppress growth of related strains by specifically binding to the 
cell envelope of susceptible cells and can mediate interspecies competition in microbial 
communities. For example, R-type bacteriocins (R-pyocins) of P. aeruginosa are potentially 
involved in the modulation of bacterial populations during host colonization (5). The production 
of antagonistic molecules varies widely in bacterial populations. The symbiotic bacterium 
Xenorhabdus nematophila produces both small compound antibiotics and R-type bacteriocins.  
Xenorhabdus nematophila engages in a species-specific mutualistic relationship with the 
entomopathogenic nematode Steinernema carpocapsae, where it resides in a specialized region 
of the anterior intestine of the infective juvenile (IJ) stage of the nematode (6–9). The IJs invade 
soil-dwelling insects, migrate to the midgut and perforates the intestinal wall to enter the body 
cavity (hemocoel) where X. nematophila is released, transitioning to its pathogenic phase. As a 
pathogen, X. nematophila produces compounds that suppress the host immune response (10, 11) 
and secretes several insect toxins and exoenzymes that participate in killing the host (12). 
Perforation of the insect gut allows microbiota to translocate to the hemocoel where they may 
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proliferate and compete for resources (8). Some transient competitors, such as antibiotic-
sensitive Staphylococcus saprophyticus, are eliminated early while other more resistant 
competitors like Enterococcus faecalis, grow in the hemolymph as X. nematophila proliferates to 
high cell density (8). In addition, more than one species of steinernematid nematode can invade 
the insect and subsequently release their respective Xenorhabdus symbioints into the hemocoel 
(13–16). Thus, in the infected hemocoel, Xenorhabdus species compete against both related 
strains and nonrelated gut microbes. 
X. nematophila produces numerous antimicrobials that can reach high concentrations 
when grown in complex laboratory media. The genome of X. nematophila encodes many non-
ribosomal peptide synthetases (NRPS) and polyketide synthases (PKS) that synthesize secondary 
metabolites including antimicrobial compounds (7). The NRPS gene clusters and stand-alone 
NRPS genes that produce the antibiotic molecules xenocoumacin (17, 18), xenematide (19), 
nematophin (20), and compounds F and C (21, 22)  have been identified. The antimicrobial 
compounds of X. nematophila are active against diverse microbial targets, but are generally not 
active against other Xenorhabdus species (23) (unpublished data).  A requisite 
4’phosphopantetheinyl (4’PP) moiety is required by NRPS and PKS proteins for enzymatic 
activity (6). Phosphopantetheinyl transferase, encoded by the ngrA gene, attaches the 4’PP 
moiety to the transfer domains of NRPS and PKS enzymes. Inactivation of ngrA thereby 
eliminates biosynthesis of NRPS and PKS-derived secondary metabolites. We have shown that 
S. saprophyticus persisted when injected alone into the insect hemocoel, but was eliminated 
when co-injected with the antimicrobial-deficient ngrA strain of X. nematophila, indicating that 
under natural biological conditions, ngrA-dependent compounds were not required to eliminate a 
sensitive competitor (21). These findings raised the question of whether NRPS-derived 
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antimicrobials were produced at inhibitory concentrations by X. nematophila during growth in 
the insect. On the other hand, S. carpocapsae reproduction in the insect was markedly reduced in 
the absence of ngrA-dependent compounds, suggesting that X. nematophila produces secondary 
metabolites that may be involved in nematode growth and development (21).  
To compete against more closely related bacteria, X. nematophila produces R-type 
bacteriocins (xenorhabdicins) that are active against a range of Xenorhabdus and Photorhabdus 
strains (24–27).  Photorhabdus spp., symbionts of heterorhabdid nematodes that also invade and 
kill insects, are the sister taxon of Xenorhabdus. We found that xenorhabdicin was required to 
eliminate Photorhabdus luminescens from co-infected insects while P. luminescens proliferated 
in insect co-infected with a xenorhabdicin-deficient strain of X. nematophila (26).  Furthermore, 
S. carpocapsae nematodes could not reproduce in co-infected insects in the absence of 
xenorhabdicin, indicating that R-type bacteriocins were essential to eliminate related competitors 
that prohibit reproduction of the nematode partner. The level of induction and spectrum of 
activity of xenorhabdicins of different Xenorhabdus species and strains can vary considerably 
(28). 
In the present study, we investigate the role of the antimicrobials of Xenorhabdus 
szentirmaii in interspecies competition in the natural environment of insect hemocoel. X. 
szentirmaii, the symbiont of the nematode Steinernema rarum (29), produces antibiotic activity 
against diverse bacteria including X. nematophila (23) and is a potent insect pathogen (30). 
While the genome of X. szentirmaii possesses many NRPS and PKS genes (31), antibiotic 
compounds have not yet been isolated from this bacterium. We show that X. szentirmaii 
primarily uses antibiotics rather than R-type bacteriocins to suppress X. nematophila in co-
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infected insects. These findings directly demonstrate that antibiotics determine the outcome of 
interspecies competition in a natural host environment.  
 
3.1. Materials and Methods 
3.1.1 Bacterial strains and growth conditions   
The bacterial strains and plasmids used in this study are listed in Table 1.  Xenorhabdus 
and Escherichia coli strains were routinely grown in Lysogeny broth (LB; 1% Bacto tryptone, 
0.5% NaCl, 0.5% yeast extract, and 0.01 mM MgSO4) or on solid media with the addition of 15 
g/L agar, at 30°C or 37°C, respectively.  For growth of Xenorhabdus strains, overnight cultures 
were supplemented with ampicillin (50 g/mL), chloramphenicol (25 g/mL), or kanamycin (30 
g/mL) when indicated and 250 L of the overnight culture was added to 5 mL of LB broth 
(1:20 subculture).  Growth was monitored by optical density at 600 nm (OD600).  Grace’s Insect 
Medium (Gibco) (Grace’s) was used for dilution plating and insect inocula.  
 
3.1.2. Overlay assay for antibiotic activity   
Overnight cultures of Xenorhabdus and insect gut strains were diluted 1:20 in LB broth 
and grown to exponential phase.  6 µL of subculture normalized to OD600 = 0.2 were spotted on 
LB agar.  After 24 h of incubation at 30°C, cells were killed by exposure to chloroform vapors 
for 30 min, followed by 30 min of air drying.  A thin layer of 1 mL of indicator strain per 12 mL 
molten top agar (LB with 0.7% agar) was poured over the Xenorhabdus colonies.  Zones of 
inhibition were photographed and measured after 24 h of incubation.  The results from four 
assays were nearly identical. 
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TABLE 1 Bacterial strains and plasmids used in this study. 
Strains and plasmids Nematode or description Geographic location Source 
    X. szentirmaii S. rarum Argentina A. Fodor 
        ngrA::Cm S. rarum Argentina This study 
        xspS::Cm S. rarum Argentina This study 
    X. nematophila    
        19061 S. carpocapsae USA Laboratory stock 
        AN6 S. carpocapsae USA Laboratory stock 
     S. anatoliense Jordan P. Stock 
 S. websteri Peru P. Stock 
    X. bovienii    
        Xb-Sf-FL S. feltiae Florida, USA P. Stock 
        Xb-Sj-2000 S. jollieti Monsanto  
        Xb-Sp S. puntauvense Costa Rica P. Stock 
    X. cabanillasii S. riobrave USA P. Stock 
    X. japonica S. kushidai Japan DMS 16522 
    X. poinarii S. glaseri USA DSM 4768 
    P. luminescens subsp. Laumondii TT01 H. bacteriophora Trinidad & Tobago T. Ciche 
 
    Enterococcus faecalis M. sexta isolate  Laboratory stock 
    Aerococcus viridans M. sexta isolate  Laboratory stock 
    Yeast M. sexta isolate  Laboratory stock 
    Staphylococcus saprophyticus M. sexta isolate  Laboratory stock 
    
    E. coli NovaBlue endA1 hsdR17 (rK12– mK12+) supE44 thi-1 recA1 gyrA96 relA1 
lac F′[proA+B+lacIqZΔM15::Tn10] (TetR) 
Novagen 
    E. coli S17-1 (λpir) recA, thi, pro, hsdR-M+. RP4-2Tc::Mu Km::Tn7 in the 
chromosome 
Laboratory stock 
   
    pSTBlue-1 Cloning vector; Amp Km Novagen 
    pKnock-Cm Broad-host-range suicide vector; Cm RP4 oriT oriR6K D. Saffarini 
    pKnock- ngrA Internal fragment of ngrA cloned into pKnock-Cm This study 
    pKnock- xspS Internal fragment of xspS cloned into pKnock-Cm This study 
Amp, ampicilin resistance; Km, kanamycin resistance; Cm, chloramphenicol resistance; Tet, tetracycline 
resistance. 
* From Singh et al,. 2014 
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3.1.3. Cell-free supernatant antibiotic activity from LB and Grace’s Medium cultures   
Overnight cultures of wild-type or ngrA strains of X. szentirmaii, or X. nematophila AN6 
were subcultured in either Grace’s Insect Medium or LB broth and grown at 30°C with shaking.  
Supernatants were harvested at 24 h and 48 h by centrifugation at 14,000 rpm for 2 min and 
sterile filtered with 0.2 µm pore size cellulose acetate syringe filters.  Aliquots of cell-free 
supernatants were frozen and stored at 4°C until the time of use.  To assess the inhibitory activity 
of antibiotic supernatants, 250 µL of overnight LB broth cultures of indicator strains was added 
to 5 mL of LB broth, grown to exponential phase, and subsequently diluted 1:200 in LB broth.  
200 µL of diluted indicator strain was mixed with 25 µL of cell-free supernatant in a 96-well 
microtiter plate and incubated for 24 h at 30°C with shaking.  Inhibition of growth (% inhibition) 
was calculated by dividing the OD600 value of treated samples by the OD600 value of untreated 
samples.  Inhibition assays were repeated at least three times and mean and standard error were 
calculated from 8-9 individual data points. 
 
3.1.4. Bioinformatics analysis of xspS gene cluster   
The xspS gene cluster was located and genes were annotated using the BlastP algorithm 
in the MaGe MicroScope platform.   
 
3.1.5. Construction of the ngrA and xspS mutant strains   
The ngrA and xspS genes of X. szentirmaii were located based on sequence homology 
using the BlastP algorithm of MaGe Microbial Genome Annotation and Analysis Platform 
(http://www.genoscope.cns.fr/agc/microscope/mage/index.php).  The ngrA and xspS mutant 
strains were constructed via insertional inactivation of the respective genes.  410 base pair (ngrA) 
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and 458 base pair (xspS) internal fragments located near the 5’ end of the genes were amplified 
using gene-specific primers (Table S1) and X. szentirmaii genomic DNA as the template.  PCR 
products were purified with GeneClean Turbo kit (MP Biomedicals), followed by end 
conversion and blunt-end ligation into the EcoRV site of pSTBlue-1 vector (Novagen).  
Successful cloning events were confirmed by colony PCR of recombinant colonies using primers 
for the T7 and SP6 promoters that flank the EcoRV site.  Colonies containing inserts of the 
correct size were grown overnight and plasmids were extracted and purified using the QIAprep 
Spin Miniprep Kit (Qiagen).  The plasmids were subsequently digested with PstI and XbaI and 
fragments containing the internal gene fragments were gel purified using the QIAquick Gel 
Extraction Kit (Qiagen).  The fragments were then ligated into the conjugal suicide vector 
pKnock-Cm (Alexeyev, 1999).  The recombinant plasmids were transformed into 
electrocompetent Escherichia coli S17-1 λpir and conjugally transferred into wild-type X. 
szentirmaii.  Exconjugants were plated on ampicillin and chloramphenicol to select for pKnock-
containing colonies.  Successful chromosomal insertion of the pKnock plasmid into the 
respective gene by single-crossover homologous recombination was confirmed by PCR analysis 
using upstream gene-specific and pKnock-specific primers. 
 
3.1.6. Polyethylene glycol precipitation of uninduced and mitomycin C-induced cultures.   
Overnight cultures of wild-type, ngrA and xspS strains of X. szentirmaii were diluted 50-
fold into 100 mL of LB broth or Grace’s Insect Medium and grown at 30°C with shaking.  
Mitomycin C (MMC, final concentration 5 µg/mL) was added to induce subcultures at an OD600 
of 0.5 to 0.6.  The uninduced subcultures were not treated with mitomycin C.  Both conditions 
were subsequently incubated at 30°C with shaking for 18 h.  Preparations were treated with 
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TABLE S1 Primers used in this study. 
Gene or 
Vector Primer Sequence (5’-3’) Use 
ngrA XSR1v1_80075 F CACCGACCTACACATAGGTTCAC mutant construction 
 XSR1v1_80075 R CAGCATCCTTGAGAATACTGGCTG mutant construction 
 XSR1v1_80075 OF CATGTTTACCCAAGCCGTTGC mutant screening 
 XSR1v1_80075 OR GAGTGTAAACGCCTGCTCG mutant screening 
xspS XSR1v1_360005 F CCATCACTACCGTTAGCACTGC mutant construction 
 XSR1v1_360005 R GCGATACCCGATGACATCTTCG mutant construction 
 XSR1v1_360005 OF GCACAAGAATATCATCACGGAGTCC mutant screening 
 XSR1v1_360005 OR GCAACCCCAGAGCATAAGC mutant screening 
pKnock pKnock-F ACACAGGAACACTTAACGGCTGAC mutant screening 
 pKnock-R TGCGAAGTGATCTTCCGTCAGAG mutant screening 
pST-Blue-1 SP6 ATTTAGGTGACACTATAG mutant screening 
 T7 CTAATACGACTCACTATAGGG mutant screening 
  
  
56 
 
1 µg/mL RNase A and DNase I for 30 min at 37°C then centrifuged and sterile filtered with 0.45 
µm pore size filters to remove cellular debris.  Xenorhabdicin-enriched fractions were 
precipitated by polyethylene glycol 8000 (10% w/v final concentration) and NaCl (1M final 
concentration) for 2 h at 4°C.  Xenorhabdicin-enriched fractions were harvested by 
centrifugation at Rmax of 13,776 x g at 4°C for 15 min, resuspended in 3 mL of LB broth, and 
centrifuged again for 5 min to remove insoluble material.  Supernatants containing 
xenorhabdicins were sterile filtered and stored at 4°C.  To prepare SDS-PAGE samples, 300 µL 
aliquots were ultracentrifuged at Rmax of 287,582 x g at 4°C for 15 min.    Pellets were 
resuspended in Laemmli buffer and 5 µL were loaded on a 8-16% PAGE gel (Genscript).  Bands 
were visualized by Coomassie blue staining. 
 
3.1.7. Microplate assay of xenorhabdicin activity  
X. nematophila AN6 was subcultured in LB broth and grown to an OD600 of 0.5 to 0.6.  
Assays of 100 µL of diluted (1200-fold) subculture mixed with 50 µL of 1X or 0.5X PEG-
precipitated xenorhabdicin were incubated in a 96-well microplate for 24 h with shaking.  
Inhibition of growth was calculated by comparing OD600 of control versus treatment wells at 24 
h.  Assays were repeated at least four times.  
 
3.1.8. Ex vivo competitions in LB broth and Grace’s Insect Medium.   
Overnight cultures of X. szentirmaii and X. nematophila AN6 were separately 
subcultured in LB broth and grown at 30°C with shaking to an OD600 exceeding 0.25.  
Subcultures were normalized to an OD600 of 0.25 and competitions were established by mixing 
1:1 ratios of X. nematophila AN6 and X. szentirmaii. Control and competition cultures were 
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inoculated with 250 µL of normalized cells in 5 mL of LB broth or Grace’s insect medium.  At 0, 
24 h, and 48 h colony-forming units/mL were calculated by dilution in Grace’s insect medium 
and plating on LB agar.  The experiments were performed three times with highly reproducible 
results.  Statistical significance was calculated by Wilcoxon matched-pairs signed rank test using 
GraphPad Prism. 
 
3.1.9. Cultivation of M. sexta larvae  
M. sexta eggs were obtained from Carolina Biological Supply and larvae were reared on 
North Carolina State University Insectary diet until fourth-instar stage as described previously 
(8). 
 
3.1.10. In vivo competitions in M. sexta  
Overnight cultures of Xenorhabdus strains were subcultured in LB broth and grown at 30°C with 
shaking to an OD600 exceeding 0.25.  Subcultures were normalized to an OD600 of 0.25 by 
dilution in Grace’s insect medium.  Competitions were established by mixing 1:1 ratios of X. 
nematophila AN6 with X. szentirmaii.  Insects were injected with 50 µL containing 103 CFU of 
respective cultures using 1-mL Sub-Q syringes (0.45-mm by 16-mm; Becton Dickinson Co.) 
mounted on a Stepper repetitive dispensing pipette (Dymax Corp.). Prior to injection, fourth-
instar larvae were anesthetized for 30 min on crushed ice and the area surrounding the horn was 
cleaned with 70% ethanol.  Larvae were placed in plastic cups until their hemolymph was 
harvested by making a cut with a sterile scissors immediately below the horn and draining the 
hemolymph into sterile 1.5 mL tubes.  Hemolymph from at least 3 insects per timepoint was 
pooled, diluted in Grace’s insect medium, and duplicate plated on LB agar.  The experiments 
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were performed four times with reproducible results.  Statistical significance was calculated by 
Wilcoxon matched-pairs signed rank test using GraphPad Prism. 
 
3.1.11. Matrix-assisted laser desorption ionization–time of flight mass spectrometry 
(MALDI TOF-MS) analysis of infected hemolymph   
M. sexta hemolymph samples from 6 insects per condition were collected 24 h post-
injection as described in the in vivo competition experiment section above.  Samples were then 
batched, centrifuged 5 min at 13,500 rpm at 4°C, and sterile-filtered with 0.45 µm pore size 
filters to remove bacteria and hemocytes.  To each 1 mL aliquot, 80 µL/mL glutathione was 
added to prevent agglutination.  1 µl of the hemolymph sample was placed on the steel MALDI 
target plate (Shimadzu Scientific, Fleximass targets TO-431R00) in triplicate and 1µl of matrix 
solution was added. The matrix solution was prepared by dissolving 10mg of α-cyano-4-
hydroxycinnamic acid in 1ml of 70% acetonitrile in 0.1% trifluoroacetic acid. The sample-matrix 
mixture on the MALDI plate was allowed to dry at room temperature. The MALDI mass spectra 
were recorded using a Shimadzu Scientific MALDI 7090 TOF-TOF mass spectrometer equipped 
with an ultrafast 2 kHz UV laser. The data were acquired by scanning in positive ion reflectron 
mode with a mass range of 150-3000 Da. The mass spectra were generated by accumulating 500 
laser shots across the sample spot. Samples from two separate experiments were assessed for 
each condition.  Each sample was analyzed in triplicate by loading sample on three different 
spots on the MALDI plate to assess the reproducibility of the results.      
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3.2. Results 
3.2.1. Analysis of antibiotic activity of X. szentirmaii 
Here we address the unresolved question of whether antibiotics play a role in interspecies 
competition between related species in a natural host environment. X. szentirmaii was shown 
previously to produce antibiotic activity against X. nematophila 19061while neither antibiotics 
nor R-type bacteriocins of X. nematophila were active against X. szentirmaii (23, 26, 
unpublished data).  To further characterize the antibiotic activity of S. szentirmaii, overlay assays 
were performed with several strains of X. nematophila and microbes isolated from the gut of 
Manduca sexta.  X. szentirmaii antibiotics were active against all strains of X. nematophila, 
although the sensitivity of the various strains varied as indicated by differences in the zones of 
inhibition (Fig 1A). The sensitivity of gut-derived microbes to antibiotics of X. szentirmaii also 
varied. Staphylococcus saprophyticus (Ss) was highly sensitive, while Aerococcus viridans (Av) 
and Enterococcus faecalis (Ef) were less sensitive (Fig 1B). 
 To determine whether NRPS and PKS enzymes were involved in the biosynthesis of 
antibiotics of X. szentirmaii, we created an ngrA strain. Inactivation of ngrA almost completely 
eliminated antibiotic activity against both X. nematophila and S. saprophyticus (Ss) as well as 
other target strains tested (Fig 1A and B; also see below).  We identified >30 NRPS genes and 2 
PKS genes in the genome of X. szentirmaii, indicating that most secondary metabolites and 
antibiotics are synthesized by NRPS enzymes in this species.  
To date, secondary metabolites have been isolated from Xenorhabdus species grown in 
complex laboratory medium such as LB broth. To assess the level of antibiotic production under 
more biologically relevant conditions, X. szentirmaii was grown in medium that mimics 
lepidopteran hemolymph (Grace’s Insect Medium) as well as in LB broth. To determine the level  
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Figure 1. Antibiotic overlay assay of the wild-type, ngrA, and xspS strains of X. szentirmaii.  
Antibiotic activity was assessed against X. nematophila strains (Xn-AN6, Xn-19061, Xn-Sw and 
Xn-Sa) and microbes isolated from the gut of M. sexta (Enterococcus faecalis, Ef; Aerococcus 
viridans, Av; unidentified yeast; Staphylococcus saprophyticus, Ss).  Zones of inhibition 
surrounding each colony is proportional to the sensitivity of the respective indicator strains. 
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of antibiotic activity produced under different conditions, filtered soluble supernatants obtained 
from cultures grown for 24 and 48 h were added to dilute cultures of the target microbe, and the 
inhibition of growth relative to the untreated culture (% inhibition) was measured. Supernatants 
from cultures of wild-type X. szentirmaii grown in LB broth for 24 h and 48 h strongly inhibited 
growth of all strains of X. nematophila (Fig 2A). The 24 h supernatants also exhibited high 
antibiotic activity against gut-derived microbes, while the 48 h supernatants were less active 
against the more resistant species, E. faecalis and A. viridans (Fig 2C). Soluble supernatant of 
the ngrA strain was inactive against all gut-derived microbes except the highly sensitive S. 
saprophyticus, which was partially inhibited (unpublished data).  The antibiotic activity of wild-
type and ngrA soluble supernatants was further analyzed against diverse Xenorhabdus species 
and the related Photorhabdus luminescens. The wild-type supernatants exhibited high levels of 
antibiotic activity against several strains of X. bovienii as well as X. poinarii, and were 
moderately active against X. japonica, X. cabanillasii and P. luminescens (Fig. S1). In contrast, 
supernatants of the ngrA strain of X. szentirmaii exhibited low levels of antibiotic activity against 
the Xenorhabdus species and P. luminescens. Culture supernatants of X. nematophila AN6 
exhibited low levels of antibiotic activity against the Xenorhabdus species and P. luminescens. 
The supernatants from X. szentirmaii grown in Grace’s possessed lower levels of 
antibiotic activity against the X. nematophila strains and the sensitivity of the strains to the 
supernatants was more variable (Fig 2B).  Supernatants were not active against the more resistant 
gut microbes, E. faecalis or A. viridans, but were highly active against yeast and S. saprophyticus 
(Fig 2D). Thus, the spectrum of antibiotic compounds and/or their concentrations produced 
under more biologically relevant conditions of Grace’s medium differed from antibiotic 
production in LB broth.  
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Figure 2. Inhibitory activity of filtered supernatants obtained from X. szentirmaii cultures grown 
for 24 h and 48 h. Cultures were grown in either LB broth (A and C) or Grace’s medium (B and 
D).  Supernatants were assayed against X. nematophila strains (Xn-AN6, Xn-19061, Xn-Sw and 
Xn-Sa) and microbes isolated from the gut of M. sexta (Enterococcus faecalis, Ef; Aerococcus 
viridans, Av; unidentified yeast; Staphylococcus saprophyticus, Ss). The % inhibition was 
calculated by dividing the optical density of treated cultures by the optical density of the 
untreated culture at each time point.  
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Figure S1.  Inhibitory activity of filtered culture supernatants obtained from X. szentirmaii wild-
type and ngrA strains and X. nematophila AN6 grown for 24 h in LB broth.  Supernatants were 
assayed against X. bovienii strains (Xb-Sp, Xb-Sj, Xb-Sf), X. poinarii (X. poi), X. japonica (X. 
jap), P. luminescens TT01 (TT01) and X. cabanallasii (X. cab). 
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3.2.2. Xenorhabdicin production in X. szentirmaii 
That X. szentirmaii antibiotics were active against X. nematophila suggested the 
possibility that both antimicrobials and R-type bacteriocins (xenorhabdicins) could be involved 
in competition between Xenorhabdus species. To address this possibility, we identified the 
remnant P2-type prophage in the genome of X. szentirmaii that contained the tail sheath (xspS), 
tube and baseplate genes but lacked capsid and replication genes (Fig S2). We had shown 
previously that inactivation of the tail sheath gene (xnpS) in X. nematophila abolished production 
of xenorhabdicin (26). Xenorhabdicin production in X. nematophila is strongly induced by 
exposure to mitomycin C. To confirm that the remnant P2 prophage of X. szentirmaii was 
required for xenorhabdicin production, we created a strain in which the xspS sheath gene was 
inactivated. Xenorhabdicin preparations were obtained from the wild-type and xspS strains by 
precipitation with polyethylene glycol (see Materials and Methods). We found that 
xenorhabdicin preparations from both mitomycin C induced (Fig 3, lane 1) and uninduced (lane 
2) cultures contained comparable levels of XspS. Thus, unlike with X. nematophila, mitomycin 
C did not induce higher levels of xenorhabdicin production in X. szentirmaii. We also showed 
that xenorhabdicin preparations from the xspS strain lacked XspS (lane 5 and 6), confirming that 
the remnant P2-type prophage cluster encoded xenorhabdicin. In addition, we confirmed that 
inactivation of ngrA did not affect xenorhabdicin production (compare lanes 1 and 3). Finally, 
we showed that inactivation of xspS did not alter antibiotic production (Fig 1A and B).  
The activity of the xenorhabdicin preparations from wild-type and xspS strains of X. 
szentirmaii was assessed against X. nematophila AN6 (Table 2). The inhibitory activities of 
preparations from the uninduced and induced wild-type strains were comparable.  This result was 
consistent with the above findings that XspS levels in uninduced cells and mitomycin-induced  
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Figure S2. Remnant P2-type prophage of X. szentirmaii. Open reading frames are classified by 
color: tail synthesis structural proteins (purple), lysis genes (yellow), truncated tail fibers (light 
green), and other uncharacterized prophage encoded ORFs (white). The xspS1 gene is designated 
as S1. Open reading frames are not drawn to scale. 
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Figure 3. SDS-polyacrylamide gel electrophoresis analysis of xenorhabdicin preparations from 
X. szentirmaii strains. Xenorhabdicin preparations were obtained from either uninduced (-) or 
mitomycin (MMC)-induced (+) cultures of the wild-type (lanes 1 and 2), ngrA (lanes 3 and 4), 
and xspS (lanes 5 and 6) strains grown in LB broth. XspS indicates the major xenorhabdicin 
sheath protein and OpnP indicates the outer membrane porin P that co-precipitates with 
xenorhabdicin. 
  
  
67 
 
TABLE 2 Inhibitory activity of xenorhabdicin of X. szentirmaii on X. nematophila AN6 
 Uninduced  Induced 
 % inhibition*  % inhibition* 
Strain 
1X 0.5X  1X 0.5X 
wild-type 89 (0.01) 24 (0.07)  80 (0.01) 30 (0.08) 
xspS 91 (0.00) 25 (0.03)  90 (0.01) 49 (0.12) 
* Numbers represent the OD600 value of the treated culture divided by the OD600 value of the 
untreated culture. 
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cells were similar. Unexpectedly, the inhibitory activity of preparations from the xspS strain was 
indistinguishable from that of the wild-type strain. This finding suggested that a non-
xenorhabdicin activity accounted for the inhibition of X. nematophila. We further assessed 
xenorhabdicin preparations from the wild-type and xspS strains against S. saprophyticus (Table 
S3). Both preparations strongly inhibited S. saprophyticus, indicating that X. szentirmaii grown 
in LB broth produced an uncharacterized non-xenorhabdicin inhibitory activity against both X. 
nematophila and S. saprophyticus that was precipitated with polyethylene glycol. This type of 
inhibitory activity had not been observed in xenorhabdicin preparations of sheath mutant strains 
of other Xenorhabdus species (26, 28, unpublished data). As shown below, this inhibitory 
activity did not contribute to the outcome of interspecies competition in Grace’s medium.  
 
3.2.3. Ex vivo competition between X. szentirmaii and X. nematophila in LB broth 
 The availability of the ngrA and xspS strains allowed us to assess the relative contribution 
of antibiotics and xenorhabdicin to the outcome of interspecies competition between X. 
szentirmaii and X. nematophila. Initially, competitions were carried out in LB broth co-cultures 
containing X. nematophila AN6 and either the wild-type, ngrA, or xspS strain of X. szentirmaii. 
We first established that the respective X. szentirmaii strains and X. nematophila grew to 
comparable cell concentrations in LB broth (Fig S3). Cultures co-inoculated with the respective 
X. szentirmaii strains and X. nematophila were incubated for 24 h and 48 h, at which time 
aliquots were diluted and plated. X. szentirmaii and X. nematophila are clearly distinguished by 
distinctive pigmentation properties. By 24 h X. nematophila was eliminated in co-cultures with 
either the wild-type, ngrA, or xspS strains (Fig 4). By 48 h, X. nematophila remained inhibited in 
the co-cultures with the wild-type and xspS strains while low levels were detected in co-cultures 
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TABLE S2 Inhibitory activity of xenorhabdicin of X. szentirmaii on S. saprophyticus 
 Uninduced  Induced 
 % inhibition*  % inhibition* 
LB 
1X 0.5X  1X 0.5X 
wild-type 95 (0.00) 96 (0.00)  95 (0.00) 95 (0.00) 
xspS 95 (0.00) 95 (0.00)  95 (0.00) 95 (0.00) 
      
Grace’s      
wild-type 95 (0.00) ND  95 (0.00) ND 
xspS 95 (0.00) ND  95 (0.00) ND 
* Numbers represent the OD600 value of the treated culture divided by the OD600 value of the 
untreated culture. 
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Figure S3. Growth of individual X. szentirmaii strains and X. nematophila AN6 used in 
competition experiments.  Strains were grown in either LB broth (A), Grace’s medium (B), or 
directly in M. sexta (C).   
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Figure 4. Pairwise in-vitro competition between X. szentirmaii strains and X. nematophila AN6 
in LB broth.  Co-cultures were established by mixing 1:1 ratios of X. nematophila AN6 and the 
respective X. szentirmaii strains and then inoculating LB broth. Competition outcome was 
determined by dilution plating at 24 h and 48 h.  The initial ratio of each competition is shown at 
time 0. Data is reported as colony forming units/ml (CFU/ml). 
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with the ngrA strain, suggesting that the production of soluble antibiotics were required to 
continually inhibit growth of X. nematophila. Inhibition of X. nematophila in co-cultures with the 
ngrA strain that lacked detectable antibiotic activity suggested that other inhibitory components 
such as xenorhabdicin and/or uncharacterized non-xenorhabdicin inhibitory activity were 
produced at sufficient quantities in LB broth to suppress growth of X. nematophila. 
 
3.2.4. Ex vivo competition between X. szentirmaii and X. nematophila in Grace’s medium 
 To determine whether under more natural biological conditions antibiotics were required 
to inhibit growth of X. nematophila, Grace’s medium was co-inoculated with X. nematophila and 
one of the respective X. szentirmaii strains. By 12 h, the cell density of both X. nematophila and 
X. szentirmaii strains increased in all co-cultures (Fig 5A). It was also apparent that the ratio of 
X. nematophila in co-cultures with either the wild-type or xspS strains decreased relative to the 
initial cell ratio at time 0, while the ratio of X. nematophila in the co-culture with the ngrA strain 
increased in comparison to the initial ratio (Fig 5B). By 24 h, the cell density and cell ratio of X. 
nematophila in co-culture with the either the wild-type or xspS strain decreased dramatically (Fig 
5A and B). In marked contrast, the cell density and ratio of X. nematophila in co-cultures with 
the ngrA strain had not decreased. Similarly, at 48 h the cell density and ratio of X. nematophila 
in co-culture with either the wild-type or xspS strain continued to decrease to barely detectable 
levels, while X. nematophila was not inhibited in co-culture with the ngrA strain.  These findings 
indicate that in Grace’s medium, soluble antibiotics of X. szentirmaii were primarily responsible 
for suppression of growth of X. nematophila. In the absence of antibiotics, X. nematophila was 
not inhibited.  
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Figure 5. Pairwise in-vitro competition between X. szentirmaii strains and X. nematophila AN6 
in Grace’s medium.  Co-cultures were established by mixing 1:1 ratios of X. nematophila AN6 
and the respective X. szentirmaii strains and then inoculating Grace’s medium. Competition 
outcome was determined by dilution plating at 12 h, 24 h and 48 h.  The initial ratio of each 
competition is shown at time 0. Data is reported as CFU/ml (A) and the ratio of X. nematophila 
AN6 relative to the total colonies counted (B). Asterisks depict statistically significant 
differences (P<0.05) as calculated by Wilcoxon matched-pairs signed rank test using GraphPad 
Prism.  
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3.2.5. In vivo competition between X. szentirmaii and X. nematophila in M. sexta 
 The above results raised the possibility that antibiotics were primarily involved in 
competition between Xenorhabdus species in the natural environment of the insect hemocoel. To 
address this possibility, co-mixtures of X. nematophila and the various X. szentirmaii strains 
were injected into the hemocoel of M. sexta and the relative amount of each strain was 
determined in hemolymph at 24 h and 48 h post-injection (Fig 6). The initial ratio of X. 
nematophila relative to the total number of cells injected is shown in Fig 6A.  At 24 h, all X. 
szentirmaii strains were present at low levels in the hemolymph, while X. nematophila was 
barely detectable (Fig 6B). The lower levels of X. nematophila were likely due to a slower initial 
rate of growth in the hemolymph (unpublished data). By 48 h, the cell density of wild-type X. 
szentirmaii continued to increase while the growth of X. nematophila was inhibited. In marked 
contrast, in insects co-injected with the ngrA strain the cell density of X. nematophila had 
increased, while the cell density of X. szentirmaii had decreased. Thus, in the absence of 
antibiotics, X. szentirmaii was not only unable to inhibit X. nematophila, but was outcompeted by 
X. nematophila. We also found that the cell density of the xspS strain increased between 24 h and 
48 h, but to a lesser extent than the wild-type strains, while X. nematophila was not fully 
inhibited.  This indicates that xenorhabdicin contributed to the full inhibition of X. nematophila 
under natural conditions of the insect hemolymph. 
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Figure 6. Pairwise in-vivo competition between X. szentirmaii strains and X. nematophila AN6 
in in M. sexta.  (A) Co-cultures of X. nematophila and X. szentirmaii strains injected into M. 
sexta larvae at the ratios indicated at time 0.  The competition outcome was determined by 
dilution plating of hemolymph obtained at 24 h and 48 h post-injection. (B) Data reported as the 
ratio of X. nematophila AN6 relative to the total colonies counted and (C) the number of colony 
forming units (CFU)/ml. Asterisks depict statistically significant differences (P<0.05) as 
calculated by Wilcoxon matched-pairs signed rank test using GraphPad Prism.  
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3.2.6. MALDI-TOF analysis of infected hemolymph 
To detect NRPS-derived compounds produced in the infected insect, we collected 
hemolymph from insects injected with either the wild-type or ngrA strain of X. szentirmaii, or 
co-injected with the wild-type strain and X. nematophila AN6, and subjected these samples to 
MALDI-TOF analysis (Fig. 7 A, B, C, respectively). In addition, hemolymph collected from 
insects injected with either X. nematophila alone or Grace’s medium was analyzed. Two species, 
m/z 544 and m/z 558, were reproducibly detected in hemolymph from wild-type infected insects 
but were not present in hemolymph from insects infected with the ngrA strain. These two 
compounds were also present in hemolymph from insects co-infected with the wild-type strain 
and X. nematophila, but were not present in hemolymph from insects injected with either X. 
nematophila alone (Fig. 7D) or with Grace’s medium (Fig 7E). The masses of these compounds 
were consistent with other peptide antibiotics isolated from Xenorhabdus species (32).  These 
findings confirmed that X. szentirmaii produced NRPS-derived compounds in insects co-infected 
with X. nematophila and suggest that these compounds may function as antibiotics that inhibit 
growth of X. nematophila in co-infected insects.   
 
3.3. Discussion 
Here we present the novel finding that antibiotics of X. szentirmaii determine the 
competitive outcome between related Xenorhabdus species in the natural environment of the 
insect host.  In the insect hemocoel X. nematophila was not inhibited when co-injected with the 
ngrA strain, but was strongly inhibited when coinjected with wild-type X. szentirmaii. In 
addition, two compounds were produced in M. sexta infected with wild-type but not in insects 
infected with the ngrA strain. Whether these compounds possess antibiotic activity remains to be 
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Figure 7. NRPS-derived compounds produced in hemolymph from infected insects detected by 
MALDI-TOF. Compounds detected in hemolymph of M. sexta injected with the following strains: 
(A) wild-type X. szentirmaii, (B) ngrA strain of X. szentirmaii, (C) wild-type X. szentirmaii and X. 
nematophila, (D) X. nematophila alone or (E) Grace’s medium. Two species, m/z 544 and m/z 558, 
reproducibly detected in hemolymph from wild-type infected insects but were not present in 
hemolymph from insects injected with the ngrA strain, X. nematophila AN6 or Grace’s medium, 
are indicated by arrows.  
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determined. Furthermore, in Grace’s medium, X. nematophila grew in the presence the ngrA 
strain, but was inhibited when cocultured with the wild-type and xspS strains of X. szentirmaii. 
These findings support the idea that during natural infections of insect hosts, X. szentirmaii 
produces antibiotics at sufficient concentrations to inhibit growth of other species of 
Xenorhabdus and Photorhabdus, and presumably gut microbial competitors. To our knowledge, 
this is the first direct demonstration of the inhibitory role of antibiotics in interspecies 
competition in a natural host environment.  
The question of whether inhibitory concentrations of antibiotics are produced in the 
hemolymph of infected insects has been addressed in the well-studied species X. nematophila.  
Maxwell et al. (33) demonstrated that extracts of homogenized Galleria mellonella killed by X. 
nematophila displayed antibiotic activity against a diverse range of bacteria. However, a 
subsequent report questioned whether X. nematophila antibiotics were produced at sufficient 
concentrations in infected G. mellonella to inhibit bacterial competitors (34). We found that S. 
saprophyticus was eliminated from the hemolymph of M. sexta co-injected with either wild-type 
or the ngrA strain of X. nematophila, indicating that the ngrA-dependent antibiotics were not 
required to inhibit growth of a sensitive bacterium (21). In addition, using mass spectrometry we 
have tried to identify the major antibiotic xenocoumacin in hemolymph of M. sexta infected with 
X. nematophila. So far, our attempts have been unsuccessful (unpublished data). Thus, the 
question of whether X. nematophila produces sufficient levels of antibiotics to inhibit potential 
competitors in the hemolymph remains unresolved. These findings raise the possibility that the 
production of antibiotics in infected insects may vary for different species, and strains of 
Xenorhabdus and may depend on the insect host in which the bacteria are growing.   
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The above findings support the hypothesis that X. szentirmaii and X. nematophila employ 
different strategies to compete against related species. X. szentirmaii appears to rely primarily on 
antibiotics to inhibit growth of Xenorhabdus and Photorhabdus species, while the contribution of 
Xsp xenorhabdicin to competitive inhibition was less pronounced. In contrast, Xnp 
xenorhabdicin is required to inhibit growth of P. luminescens in co-infected insects while X. 
nematophila antibiotics are not active against Xenorhabdus and Photorhabdus species. These 
findings suggest that X. szentirmaii produces potent antibiotics that may be expressed at high 
levels in the insect hemocoel. We have identified >30 NRPS genes in the X. szentirmaii genome, 
several of which may be involved in antibiotic synthesis. We identified NRPS genes for 
production of rhabdopeptides, linear nonpolar peptides with cytotoxic activity towards insect 
hemocytes (35), and the large NRPS gene for the synthesis of GameXPeptides produced by 
Xenorhabdus and Photorhabdus species (36). The function of GameXPeptide is not presently 
known. Interestingly, the production of GameXPeptide in X. szentirmaii was dramatically 
increased by ectopic production of the LeuO regulatory protein from X. nematophila. In X. 
nematophila, LeuO differentially regulates NRPS genes, while Lrp positively regulates NRPS 
genes (37). In addition, we have shown that NRPS genes are negatively regulated by OmpR (17). 
Whether elevated expression of NRPS genes in X. szentirmaii confers the ability to inhibit 
growth of related bacteria in the insect hemolymph remains to be determined. In this regard, 
comparative analysis of the regulatory circuitry of NRPS genes in X szentirmaii and X. 
nematophila grown under natural conditions could help elucidate differences in the regulatory 
mechanisms that underlie the different competitive strategies of the respective bacteria.  
 Besides producing high levels of antibiotic activity, X. szentirmaii rapidly kills insect 
hosts such as M. sexta (unpublished data). In addition, the S. rarum-X. szentirmaii complex has 
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been shown to be highly virulent towards several agricultural insect pests (29, 30). A trade-off 
between host exploitation (virulence) and competitive ability has been demonstrated for related 
strains of X. bovienii (38). X. bovienii CS03 produced high levels of antibiotic activity against 
diverse bacteria, but was nonvirulent when injected into insects, while X. bovienii SS2004 gained 
a fitness advantage by effectively killing and exploiting the host, but did not produce antibiotics 
against most of the bacterial targets tested. X. szentirmaii represents an alternative strategy that 
includes both a high level of virulence and production of antibiotics that are active against both 
gut microbes and other species of Xenorhabdus. Whether trade-offs occur in other aspects of the 
S. rarum-X. szentirmaii life cycle, such as lower levels of nematode fitness (39) or reduced 
nematode colonization (40) remains to be determined.  
 The contribution of ngrA-derived antibiotics to competitive outcome was not detected in 
competition experiments in LB broth in which X. nematophila was eliminated in co-cultures with 
the ngrA strain. It appears that X. szentirmaii produced an ngrA-independent inhibitory activity 
in LB co-cultures that was not present in co-cultures in Grace’s medium or in infected insects. 
We also found that antibiotic activity of supernatants from LB broth cultures was considerably 
greater than supernatants from cultures in Grace’s medium. Similarly, we showed previously that 
total antibiotic activity and xenocoumacin levels in supernatants from LB cultures of X. 
nematophila were much higher than in supernatants from Grace’s medium (21). Growth of 
Xenorhabdus species in nutrient-rich laboratory broth apparently enhances the production of 
secondary metabolites that facilitate isolation and identification of antibiotic compounds. On the 
other hand, the inhibitory activities produced in laboratory medium but not under more natural 
growth conditions may mask the contribution of antibiotics to interspecies competition. These 
findings point to the value of assessing interspecies competition and the production of antibiotics 
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in natural environments (41, 42). Furthermore, some antibiotics may be produced during growth 
in natural environments but not in laboratory medium, providing an opportunity to discover 
novel antibiotic compounds.  
 The role of antibiotics in a natural environment has been widely studied in the symbiosis 
involving the fungus-growing attine ant and actinomycetes bacteria (43–45). Pseudonocardia 
commonly associated with the attine ants produce a cyclic depsipeptide, dentigerumycin, that 
inhibits the Escovopsis fungal pathogen when grown on agar medium or in liquid broth (46). The 
NRPS-containing biosynthetic cluster for dentigerumycin biosynthesis has recently been 
identified (47). Pseudonocardia strains also produce antibacterial activity against gram-negative 
and gram-positive bacteria (48). In addition, ant-associated Streptomyces strains thought to be 
acquired from the nest environment produce the fungicidal agent nystatin that may also 
participate in interspecies competition (49). Thus, numerous types of antibiotic activities are 
potentially involved in sustaining the multipartite attine ant symbiosis. It is not yet known 
whether a few or several antimicrobial compounds are produced in sufficient quantities in nature 
to inhibit Escovopsis and other competitors. In this regard, further studies on the production and 
function of antibiotics of Xenorhabdus species in natural environments will help us better 
understand the role of antibiotics in interspecies competition in microbial communities.  
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